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INTRODUCTION 
The immune system is a tremendously complicated and important system, whose central players, 
the lymphocytes, are able to recognize specific foreign invaders (antigens) with their specific cell 
surface receptors (immunoglobulins on B-lymphocytes and T cell receptors on T-lymphocytes). A 
number of different subpopulations of lymphocytes assume the various functions of the immune 
response: B cell/plasma cell production of specific immunoglobulin, helper/inducer T cells, 
suppressor T cells and specific cytotoxic T cells. Each of these lymphocyte subpopulations i  
composed of a large number of clones which each respond to specific antigens via their cell surface 
receptors. The study of lymphocyte kinetics involves cellular proliferation and differentiation under 
two different conditions: (1) the initial generation of the repertoire of lymphocytes, each of which 
displays a specific ell surface receptor, occurs in the absence of triggering by antigen; and (2) the 
specific clonal lymphocytic proliferation and differentiation occurs in response to antigen recog- 
nition by these receptors. Both processes involve considerations of cell cycle kinetics and 
population dynamics, and neither is completely understood. 
One approach to the study of complex systems, along with the experimental pproach, is to 
construct mathematical models of the processes. Most of the mathematical models of the immune 
system have focused on the second phase, the antigen-induced activities (for reviews, see Refs [1-6]). 
This work will focus on the first phase, the development of the lymphocyte repertoire. Mathe- 
matical treatment of the development of the lymphocytes i limited to early models of thymus 
cellular kinetics constructed before the lymphocyte subpopulations and precursors were described. 
A thorough search of the literature showed no work in this field for the last 10 years. The current 
level of understanding of lymphocyte differentiation makes this an untapped fertile field for 
theoretical research. It is the purpose of this work to encourage such theoretical research by 
(1) reviewing mathematical treatment of lymphocyte differentiation or analogous 
systems; 
(2) providing a coherent review of lymphocyte differentiation as it is now under- 
stood; 
(3) raising the crucial questions which remain to be solved in this field; 
and 
(4) suggesting mathematical treatment which may be helpful in resolution of those 
crucial questions. 
First, an overview of the immune response will be provided as background. Then, using selected 
models of the antigen-induced phase of the immune response as examples, theoretical methods will 
be reviewed. The current understanding of the differentiation sequence of each subpopulation of
lymphocytes will be described in detail, along with an examination of relevant models. Similarly, 
lymphocyte migration, including the only existing theoretical treatment, will be discussed. Finally, 
the conclusions will include a summary of the crucial questions identified and suggestions of 
possible theoretical treatments. 
In order to construct a mathematical model of lymphocyte differentiation, certain pieces of 
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information are required. The basic questions are: 
(1) What are the stages of lymphocyte differentiation as defined by markers of 
specific cell types? 
(2) What is the sequence of differentiation i  each lymphocyte subpopulation? 
(3) How many cells of each type are in the lymphoid tissues at different times during 
ontogeny? 
(4) How are these cells distributed between dividing cells and resting cells? 
(5) What is the generation time for the dividing cells? 
(6) What is the product of the division, i.e. is the cell a self-renewing population 
or does it divide into cells which are further differentiated? 
(7) How long does a particular cell remain in each population? 
(8) How many cells die at each stage of differentiation? 
(9) How is the repertoire of cells with specific receptors generated and controlled? 
(10) Which cells migrate and to which tissues? 
(11) What is the rate of migration of each cell type into and out of each tissue? 
The process of model construction makes quite apparent which pieces of information are lacking 
and organizes those which do exist. The reader will find that the information available about 
lymphocyte differentiation varies from cell populations which are only hypothesized to relatively 
well-described populations with known cellular kinetic parameters. 
L ymphocytes 
Mature lymphocytes are divided into two major populations, B-lymphocytes (B cells) which 
display specific antibody structures, and T-lymphocytes (T cells) which also display specific antigen 
receptors called T cell receptors. Both populations have several subpopulations which will be 
described in detail in the sections B Cell Differentiation and Intrathymic T cell Differentiation. B 
cells mature in a dedicated organ in birds, called the Bursa of Fabricius, which is the origin of the 
name B cell. However, in mammals the differentiation f B cells occurs in the bone marrow which 
also provides other hemopoietic precursors including the cells that migrate to the thymus to become 
T cells. 
Upon an encounter with an antigen which will bind to the specific receptor, the mature, 
non-dividing lymphocyte is activated to become a dividing cell, proliferates through several 
divisions (5-10) and differentiates into a mature cell. Different subpopulations of T cells either 
perform acontrol function, inducing or suppressing specific effector lymphocytes (B cells or T cells), 
or differentiate into specific cytotoxic effector cells. B cells differentiate into plasma cells which 
secrete large amounts of the particular antibody molecule which has been displayed. 
Early studies on lymphocyte kinetics 
Detailed cellular kinetic studies were done on lymphocytes over 20 years ago, before the 
discovery of the different subpopulations. Everett et al. [7, 8] demonstrated both short-lived 
lymphocytes with half-lives of less than 2 weeks and long-lived lymphocytes with half-lives of 
at least several months. The lymph had a lower percentage of short-lived lymphocytes (10%) 
than the blood (35%). The blood contained lymphocytes from a source that had a direct entry (i.e. 
without going through the lymph first) and that this source was highly proliferative. They observed 
that this could not have been the thymus because the cells leaving the thymus were weakly labeled 
with tritiated thymidine while the cells in the blood were strongly labeled. This indicates that the 
cells coming from the highly proliferative source (probably the bone marrow) did not divide as 
many times, diluting out the strong label. The half-time turnover of cells in the bone marrow was 
24 h. 
Immune response 
Extensive research as been applied to study the immune system's response to a foreign antigen. 
As a result, this area is relatively well-understood. The brief synopsis which follows is necessarily 
a vast simplification. The reader is referred to recent extbooks for more detailed escriptions 
[9-11]. 
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There are two arms of the immune response, distinguished by the nature of the final effector. 
Humoral immunity can be transferred from an immune animal to another animal by the injection 
of serum which includes antibody molecules, but is free of cells. Cell-mediated immunity, on the 
other hand, requires the transfer of lymphocytes from an immunized animal. 
The immune response begins with the introduction of an antigen which is taken up by an 
antigen-presenting cell (either a macrophage ora B cell) and degraded with the fragments presented 
to the helper T cell in the context of a self-marker (cell surface class II major histocompatibility 
antigen called Ia). If the specific receptors on the surface of the helper T cell recognize both the 
antigenic fragment and the self Ia, the helper T cell is activated and proliferates. The mature B 
cells that recognize the antigen through their surface receptors interact with the helper T cells, and 
the antigen-presenting cells, and pass through the same activation and proliferation stages prior 
to differentiation. The resulting amplification produces a large number of B cells responding 
specifically to the current antigenic invasion. During the amplification somatic mutation of the 
genes coding for immunoglobulin allow for the generation of additional diversity in the antigen 
receptor. 
After activation and proliferation, B cells differentiate into plasma cells which secrete large 
amounts of the same antibody which was displayed on the surface of the progenitor B cell. Plasma 
cells are non-dividing and short-lived, having the single purpose of producing antibody specific for 
the invading antigen. Their demise at the end of a cycle of immune response isone means of control 
of the humoral immune response. 
The T inducer cells allow the production of the cytotoxic T cells responsible for the destruction 
of cells infected with an intracellular parasite, such as a virus, or displaying some other 
abnormality, such as malignant cells. This is a very important component of the immunity against 
intracellular parasites uch as viruses because viruses are unaffected by antibody once they have 
infected a cell. The only way to control the infection at that point is to rid the host of the infected 
ceils. For this response it is necessary that a specific antigen, foreign to the host, be on the surface 
of a cell which also carries the self class I major histocompatibility antigens. 
A proportion of the responding lymphocytes, both B and T cells, differentiate into memory cells 
rather than effector cells. These memory cells are part of the long-lived lymphocyte population and 
are mature, resting B- and T-lymphocytes that are ready to respond to a second invasion of the 
same antigen. The response is controlled by the induction of T suppressor cells. This is thought 
to be the mechanism of the self-tolerance which prevents the immune system from responding to 
its own antigens and self-destructing. 
Numerous oluble factors have been isolated that mediate the activation, proliferation and 
differentiation f lymphocytes. Interleukin-1 (IL-1), produced by the macrophage, facilitates the 
activation of T inducer/helper cells which have recognized the specific antigen-self Ia complex. 
These activated T inducer/helper cells then make receptors for interleukin-2 (IL-2) and sub- 
sequently produce IL-2 molecules which are required for proliferation of T cells and which also 
stimulate the proliferation of B cells. Other factors involved in specific reactions include 
~-interferon (which acts as a B cell differentiation factor), another B cell growth factor, helper 
factors and suppressor factors. 
MATHEMATICAL MODELING METHODS 
Most of the mathematical treatments of lymphocyte kinetics are in the context of the 
antigen-induced phase of the immune response. This work has been reviewed extensively and will 
not be duplicated here [1-6]. Instead, this section will concentrate on selected works to demonstrate 
the different approaches which have been taken. 
Cellular kinetic models 
Most models of cellular kinetics can be applied to the study of lymphocyte kinetics. While it is 
beyond the scope of this review to consider all available models, a comparison of the types of 
mathematical models of cell growth is instructive [12]. Partial differential equations were used to 
consider two variables: time and age of each cell [13], 
On(a, Q/at + ~n(a, t)/aa = O, t ~ [0, T], 
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where n(a, t) is the cell density per age unit, t is time and a is cell age which ranges from a = 0 
just after mitosis to a = T just prior to the next mitosis. The boundary condition, n(0, t), equals 
2n(T, t) because at a = T, binary fission occurs. Further refinement of this model added a 
coefficient for the loss of cells, 
l(a, t) = li(a) + ld(a, t), 
where li is the probability of loss of cells from a population due to mitosis and ld is the probability 
of loss of cells due to death [14]. Thus, the partial differential equation becomes 
On(a, t)/Ot + On(a, t)/Oa = - l (a ,  t)n(a, t). 
Since the age of a cell is assumed to range from 0 to ~,  the boundary condition 
n(O, t) = . I f  2n(a, t)li(a) da 
was used. Another variation of this model changed the age variable to a maturity variable (m) 
which considered size or DNA content of the cell and varied from m = 0 just after mitosis to n = 1 
at full maturity just prior to mitosis. The maturity variable had a velocity function, v(m, t), which 
was used to explain the distribution of generation times in a cell population: 
On(m, t)/Ot + O[v(m, t)n(m, t)]/Om = -ld(m, t)n(m, t), 
with the boundary condition v(0, t)n (0, t) = 2v (1, t)n (1, t). When the additional variables are set 
to zero and the additional functions assumed to be constant, these refined models are equivalent 
to the first one described. 
Models involving difference quations are especially conducive to the use of the digital computer. 
Cells are assumed to be contained within N compartments, each corresponding to a cell age 
between the prior mitosis and the next mitosis [15, 16]. If the generation time of the cell population 
is To and the initial time is to, at t = to + To~N, the cells will have advanced one compartment. If 
k is taken as the number of time intervals, then at the time interval k + 1 the cells will have 
advanced one component. The transition from x(k) to x(k + 1) is accomplished using the unit time 
shift operator, S. To account for the probability that some cells will age faster or slower than others, 
a unit dispersion operator, D, is constructed which is a matrix subtracting the fraction of cells that 
would remain in the same compartment instead of advancing and those that would advance two 
compartments rather than one. The difference quation relating the state vector at the (k + l)th 
time interval with that at the kth time is 
x(k + 1) = P(k + 1, k)x(k),  
where P(k + 1, k) = DS. This model has been generalized to separate the cell population into the 
proliferating pool and the non-proliferating pool. 
Differential equations, derived from population studies, have been used to study cellular kinetics. 
The general form of these equations is 
N(t) = g(N(t)), N(O) = No, 
where N(t) refers to the number of cells at time t and g(N) is the growth function, which allows 
the cell population total to approach some critical size. An example of such a function is that 
proposed by Simpson-Herren and Griswold [17]: 
N(t ) = -- aN(t) In [N(t)/Nm ], 
where a is a constant and Nm is the maximum number of cells expected. 
Sundareshan and Fundakowski [12] use the multicompartmental model of Takahashi [18, 19] to 
determine the conditions under which the models using partial differential equations, those using 
difference quations and those using ordinary differential equations are equivalent. 
X-  Y -Z  models 
Jilek and Prikrylova [20] examine the models which use the X-Y-Z scheme first described by 
Sercarz and Coons [21] and Sterzl [22]: X represents the circulating cells with the potential to 
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respond to a particular antigen, Y cells are the progeny of X cells activated by the antigen to 
proliferate and Z cells are the differentiated progeny of Y cells that are now able to produce 
antibody for a limited time. The authors provide a very useful comparison of X-Y-Z models 
showing the varying terminology used for X, Y and Z cells. They concluded that the X-Y-Z scheme 
works well in representing the immune response and probably will continue to be used. 
An example of such a model is ABIGAIL (Table 1) which was constructed by Bell [23-25]. In 
ABIGAIL, considerations of chemical equilibrium are used to simulate the interactions ofantigen 
and antibody, whether on the surface of X cells or as free molecules in the circulation. The model 
considers a number (J) of cellular populations having receptors with a range of affinity constants 
for binding with a particular antigen. Binding constants (kj) were used to determine the fraction 
of group j receptor sites bound to antigen (rj): 
rj = k j f  /(1 -1- k j f  ), 
where L is the number of unbound antigen sites. A threshold fraction (frnin) of occupied receptor 
sites on the surface of X cells triggered the transformation of that cell into a Y cell that 
divides through a given number of divisions before differentiating into a Z Cell which produces 
antibody. The proportion of cells stimulated is determined by 
Ry = r/fmin, Fj = Ry/(1 q- Rj), tty= (Ry- 1)/(Ry-t- 1). 
The parameters Fyand/-/y determine the stimulation of target and proliferating cells, respectively, 
in the cellular kinetic equations hown in Table 1. As more antibody is produced, the antigen is 
bound by the free antibody and is not available for binding to the membrane-bound antibody on 
X cells. Thus, the clearance of antigen and cessation of the immune response is simulated. 
In a report which combines considerations of the development of lymphocytes with the effect 
of the immune response, Lumb and Morrison [26] used THYMS [27, 28], which simulates the 
differentiation of mature lymphocytes, as the source of immunocompetent cells (X cells) in the 
ABIGAIL model. The THYMS equations, shown in Table 2, will be derived in later sections 
(Theoretical Approaches to the Progenitor Cell Problem and Theoretical Approaches to the Thymus 
Problem). Although THYMS was designed as a model of the production of T cells by the thymus, 
it was used in this interfaced model (THYMS/ABIGAIL) as an approximation f the production 
of B cells in a thymus-independent immune response. Since THYMS was capable of simulating 
the recovery of the immune system from irradiation, it was possible to test the effects of different 
levels of irradiation upon the immune response in the model and compare the data with that 
obtained in experimental systems. The results were similar, verifying this model. 
Kaufman et al. [29] use formal logic in a fresh approach to the derivation of a system of 
differential equations. This model gives values of 0 or 1 to the elements of the system (virgin B 
cells, mature B cells, T helper cells, T suppressor cells, antibody and antigen), depending on whether 
or not the concentration is greater than a threshold value. The rate of production of each variable 
is also given a logical value of 0 or 1, depending upon whether or not it is great enough to be 
considered. The differential equations derived to assign the logical value are similar to those 
described in ABIGAIL except hat this model also includes the inhibition of responses caused by 
T suppressor cells.The advantage of this approach is that the state of the system can be considered 
separate from the quantitative r sults of the differential equations. 
Predator-prey models 
The Volterra-Lotka equations [30-32] developed for the mathematical treatment of the 
predator-prey relationship have been applied to the immune response where the antibody molecule 
[33] or the B cell/plasma cell [34] is considered to be the predator and the antigen to be the prey. 
The similarity to the predator-prey situation lies in the fact that both the predator and prey are 
self-replicating or are produced by self-replicating entities. When an interaction occurs, the prey 
(antigen) is eliminated from the system. The equations from Dibrov et al. [34] for antibody, A (t), 
antigen G(t)  and target cell X(t )  concentrations at time t are 
dA (t)/dt = aX(t  - T)g (t - T )S ( t  - T) - rG(t )A (t) - eA (t), 
dG(t) /dt  = kG(t  ) - qG(t )A  (t) 
C.A.M.W.A. 1419-12--B 
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Table 1. Equations used in ABIGAIL (shown as modified for the interface with THYMS) 
J ffi Number of classes of cells with different affinity constants for binding to antigen 
N~.j(t) = Concentration of type i cells in group j, where i = 1, 2, 3, 4 denote respectively target, proliferating, plasma and 
memory cells, j = 1, 2 . . . . .  J 
Fp = Fraction of proliferating cells that become plasma cells 
Fj = Parameter reflecting how close a target cell is to being sufficiently bound to antigen to become a proliferating cell 
Hj = Parameter reflecting how close a proliferating cell is to being sufficiently bound to antigen to divide 
T I = Mean time for the target cell to become a proliferating cell 
T 2 = Mean time for division of a proliferating cell 
T~, T~, T 3, T 4 = Mean time (respectively) for death of target, proliferating, plasma and memory cells in the absence of antigen 
T2(t) = Function which limits proliferating cells to a specified maximum 
Elimination of antigen--antibody complexes 
Abj(t) = Concentration of antibodies in group j
Ag(t) = Concentration of antigen molecules 
T 5, T~, T 6 = Mean time (respectively) for removal of antigen combined with antibody, free antibody and free antigen 
r/= Fraction of antibody sites bound to antigen 
c 2, c 3 = Number of antibody molecules produced per unit time (respectively) by proliferating cells and plasma cells 
n = Number of sites per antigen molecule for binding to antigen 
Concentration of antibody 
dabj 
dt = c2N2"j 
+c3N3.j 
2rj 2 l~ . , r jAby(1 - ; )+ l  
n r  5 Ag Ab, 
--AbJr; 
Concentration of antigen 
dAg = S(t) 
dt 
- 2~rjAbl/nT5 
-2  ~ rjAbj/nT 5 
j=l  
-- Ag /T 6 
Concentration of target cells 
dNl,~(t) 
dt -FjNLJ 
+(1 - Fp)(1 - Hj)N2,j/T 2 
-- NI,j/T' I
+ Lym (t) 
Concentration of proliferating cells 
dN2,j(t) 
dt F/NI"j/TL 
+ HjN2,i/T2(t) 
-- N2, j~ T~ 
Concentration of plasma cells 
dN3,j(t) 
dt Fp(l - Hy)N2,j/T2(t ) 
-- N3.y/T3 
Concentration of memory cells 
dN4'/(t) (I - Fp)(l - Hj)N2,j/T2(t ) 
dt 
--N,,j/T4 
(Source of antibody produced by proliferating cells?) 
(Source of antibody produced by plasma cells) 
(Elimination of antibody bound to sufficient antigen) 
(Elimination of all antibody) 
(Imposed source of antigen) 
(Elimination of antigen bound to antibody) 
(Elimination of all antigen) 
(Loss of target cells to proliferating population) 
(Addition of memory cells to target cell population) 
(Target cell death) 
(Target cell input from THYMS) 
(Source of proliferating cells due to transformation of target cells) 
(Multiplication of proliferating cells) 
(Proliferating cell death) 
(Source of plasma cells due to differentiation of proliferating cells) 
(Plasma cell death) 
(Source of memory cells due to differentiation of proliferating cells) 
(Memory cell death) 
and 
dX( t ) /d t  = J - X ( t ) /d  -pX( t )G  (t) + mX(t  - M)G (t - M)S( t  - M), 
where a, r, e, k, q, p and m are arbitrary coefficients; T is the time delay between the stimulation 
of X cells and the production of antibody by Z cells; M is the time delay between the stimulation 
of X cells and the appearance of memory cells in the target cell pool; S( t )  is a step function which 
is equal to 0 if t < 0 and equal to 1 if t > /= 0; J is the rate of appearance of target cells from 
precursor populations; and d is the average lifespan of target cells. This model and that of Bell 
[24] both result in oscillating systems, which has been also observed in natural immune responses 
[351. 
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Bone marrow compartment 
Li dL, ~ 2(i -~)G,L, 
dt k 
dS~ 
- -  = - DG~ Sm 
dt 
Thymus compartment 
dLj+, = 2GjL)--Gj+,Lj+, 
dt 
dL~=2Gn iL .  i - -0 .017Ln 
dt 
Blood vessel compartment 
dE 
d~ = 2GeE 
1 NPT  k 
G~ Tk--Tk_1 
- -  ~-50 
Irradiation compartment 
Calculate fraction of cells remaining (F) 
F /= 0.37 exp(D/D37) 
t = Time 
L~ = Stem cell population 
Sm= Maximum number of stem cells allowed 
G I = Reciprocal of  generation time of stem cells 
L 2 = Number  of lymphoblasts 
D ~ Rate of decrease of  S m (degeneration parameter) 
Lj = Number  of cells in the jth generation 
Gj = Reciprocal of  generation time of the jth generation where 2j = n - 1 
L, = Number  of cells in the last generation in the thymus 
G,_ ~ = Reciprocal of  generation time of the (n - l)th generation 
E = Total number of endothelial cells 
G e = Reciprocal of  generation time of endothelial cells 
NP = Nutrition parameter 
T~ = Total number of lymphocytes in the kth iteration of the model 
D = Dose of irradiation 
D37 = Dose of irradiation of j th  type of cell at F /= 0.37 
Decrease number of cells in population of j th  type of cell by F/ 
/) = F:L/ 
Decrease cell division following irradiation 
/120-  T'~ 
G,=Go~-)  - F/ 
Optimization and control theory 
Optimal control theory has been used to advantage in the design of models of the immune 
response [36-38]. The assumption that the immune system has evolved by natural selection suggests 
that optimal conditions would be selected for. However, evolutionary changes are only miniscule 
changes in any one time interval. Therefore, one would expect hat the system would be optimized 
within a limited range of possibilities which are bounded by lethal conditions. Thus, mathematical 
treatments which determine the general optimal condition may not be applicable to the natural 
situation [39]. Nevertheless, optimal control theory seems applicable within the boundaries of 
specific aspects of the immune response. For example, one can ask the question: What is the 
optimal number of divisions of lymphocytes during the proliferative stage of an immune response. 
If too many divisions occur, the response will be high because of all the effector cells eventually 
produced, but it will be too late to be of any use in the immune response. If too few divisions occur, 
the response will be timely, but too low. 
Perelson et al. [36] designed a model to address this question: 
dA/dt = k(L + nP), 
dL /dt = bu( t )L - m[1 - u( t )]L -dL ,  
dP /dt = m[1 - u( t )]L - eP, 
where A, L and P are the concentrations of antibody, lymphocytes and plasma cells; k is the rate 
of production of antibody by proliferating cells and n is the incremental increase of this rate in 
plasma cells; b is birth rate of the fraction u(t) which continues in the lymphocyte population and 
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m is the maturation rate of the 1 - u(t)  fraction of lymphocytes which mature into plasma cells; 
and d and e are the death rates for lymphocytes and plasma cells, respectively. The objective was 
to select he function u (t) which minimizes the time required to reach the concentration f antibody 
which will neutralize the given amount of antigen. In control theory this is called the cost function. 
They applied the maximum principle of Pontryagin which involves the definition of a Hamiltonian 
(H), a scalar function (for detailed escriptions the reader is referred to texts by Athans and Falb 
[40], Leitmann [41] and Clark [42]): 
where 
and 
H = Vofo + Vt [k (L  +nP) ]  + V2[bu - m(1 - u) - d]L + V3[m(1 - u)L  - eP], 
110 = const/> 0 and V,, 1/2 and 1/3 satisfy 
dV, /d t  = -H /A  =0 
dV2/dt = - H /L  = - -kV l  -- [bu - m(1 - u)  - d]V2 - m(1 - u)V3 
dV3/dt = -K /P  = -nkV~ + eV3, 
with the final conditions Vj (T) = 1, V2(T) = V3(T) = 0. They found the control to be "bang-bang" 
which means that it is an on-off switch. Collecting all the terms in H which involve u, 
H = [(b + re)V2 - mV3]Lu + all other terms, 
provides a switching function, f ( t )  = (b + m)V2( t )  - mV3(t ) ,  which maximizes H if u(t)  = 1 when 
f ( t )  > 0 and u(t)  = 0 whenf(t)  < 0. In this way the model will predict he time when the u(t)  should 
change from 1 to 0, i.e. the time when the natural system will change from the proliferating 
lymphocyte stage to the stage where the lymphocytes differentiate into plasma cells. Similar 
methods have been applied to models of the immune system including memory cells and optimizing 
the IgM-IgG switch [43, 44]. 
Another optimization method is the iterative solution to the problem of the traveling salesman 
who needs to visit N cities in a particular area and wants to minimize the total distance traveled. 
Brady [45] used this problem to learn some optimization strategies from evolution. There are N! /2  
possible solutions. In the first strategy, a trial solution was selected at random and changes were 
made in this solution only if the total distance traveled was reduced. To consider the effect of 
competition, the simulation then tested two trial solutions against each other, duplicated the better 
of the two, and discarded the remaining one. This strategy did not work as well as the one without 
competition because it reduced iversity. To increase diversity, a strategy simulating mating and 
genetic recombination was devised. Sections of each of the two competing solutions were compared 
and the shortest was duplicated for both solutions. In this way, the competition was at the gene 
level, rather than at the level of the individual organism. The gene level competition produced the 
most efficient results of the three strategies used. Although this method requires a tremendous 
amount of computer time, because of the faster supercomputers available today, this is not a severe 
limitation. 
Network  theory 
Jerne [46, 47] described a theory of immune system control based upon the observation that 
specific antibodies could act as antigen in the syngeneic host. The idiotypic determinants (antigenic 
determinants located in the highly variable regions of the antibody structure) are not subject o 
the normal self-recognition and anti-idiotype antibodies are produced. Jerne suggested that this 
allowed a mechanism for control of the immune response. The sequence goes like this: a foreign 
antigen(+) induces the production of specific antibody with an idiotype(-); when the concen- 
tration of that idiotype(-) gets large enough, it acts as an antigen and induces anti-idiotypic(+) 
antibody which is suppressive of the production of the original antibody(-);  then the concen- 
tration of the anti-idiotype(+) antibody with its own specific idiotype gets high enough to induce 
a second level anti-anti-idiotype(-) antibody which can go on to suppress the anti-idiotype 
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antibody. The theory is called the "network theory" because of the network of interacting 
complexes of idiotype-anti-idiotype-anti-anti-idiotype. 
The model by Richter [48] uses the network theory to investigate the experimentally-induced 
tolerance with very small, continuous doses of antigen (low zone tolerance) and with very high 
doses of antigen (high zone tolerance). In this model they assume that all receptors bind with the 
same binding constant, K, and consider the birth and death of I cells with the original idiotype, 
which occur at rates b and d. The following interactions of the receptors on lymphocytes (I) with 
antigen (I-) or anti-idiotype antibody (I+): 
(1) activation of I with I-  
(2) inhibition of (1) with I ÷ 
(3) destruction of I by I ÷ 
(4) protection against (3) by I- 
affect the I cells. These are described by the differential equation: 
dI/dt = I[bB(I +, I-) - dD(I +, I-)], 
where B is the fraction of lymphocytes (I) currently being activated by I-  and D is the fraction 
of I currently being destroyed by I +. Using chemical equilibrium, the concentration of receptors 
on the I cells that are bound with antigen (RI-), with anti-idiotype antibody (RI +) or with both 
(I-RI +) are: 
RI-  --- K[i -][R + ], 
RI + = K[i +] [R+ ] 
and 
I -R I  + = qK[i-][i+][R+ ], 
respectively, where i, i -  and i + are the free antibody, antigen and anti-idiotype antibody 
concentrations, R+ is the unbound receptor and q is a parameter decreasing the binding of two 
antibodies to one receptor because of steric hindrance. The fractions B and D are given by 
and 
where 
]/ B=I -  k yk ( l+y;)M 
]/ D = 1 -- z k (1 +Zl)M, 
0 k 
y, = [I-](l + qK[I+])/(1 + K[I+]) 
and 
z, = [I+](1 + qK[I-])/(1 + K[I-]), 
and u, M and v are parameters. They demonstrate hat there is a sharp threshold for activation 
at u/M and for suppression at v/M. This model was applied to conditions under which tolerance 
was induced, i.e. with either very low doses of antigen or very high doses of antigen. They 
demonstrated that network theory could explain these phenomena. 
There is also experimental evidence that idiotypes will induce the production of suppressor cells 
and contrasuppressor cells [49, 50]. This suggests that not only antibody, but also lymphocytes may 
participate in a network of control of the immune response. One model assumes that clusters of 
lymphocytes form during the idiotype-induced suppression reactions [51]. Lymphocytes within 
these clusters were suppressed. Free lymphocytes were allowed to develop into effector cells. All 
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reactions were also reversible and a cluster (chain) was also allowed to decay. A series of differential 
equations were developed for the single cells, x, and chains of length n cells varying from 2 to N: 
N- I  N - I  
dx/dt =-kx2-kx  ~ Cn+2r ~ C n 
n=2 n=2 
dCn/dt = -kxCn + kxCn_ I - 2rCn + 2rC~+ 1 
dCN/dt = kxCN_ i -- 2rCN, 
where k is the rate of addition of one cell to a chain, k/2 is the rate of association of two single 
cells, r is the rate of decay of the association between two cells and 2r is the rate of decay of a 
chain by removal of one cell. The simulation was run until it reached equilibrium, so the system 
satisfied the condition 
dN/dt=d(x+ ~ 
with the solution C~ = x(kx/2r) ~-I. This model was applied to the interpretation of limiting 
dilution experiments in which T cells are exposed to polyclonal activators, growth factors and 
maturation factors, and then assayed for resulting effector cells. These experiments provide 
information as to the number of precursor cells which were available for development into the 
effector cells measured and the size of clones developing under these conditions. These data allowed 
the construction of a model of the lymphocyte control network. Another model of network 
regulation of suppression determines what configuration of suppressor cells, effector cells and 
contrasuppressor cells is most advantageous [52, 53]. 
Stochastic approach 
A refinement of previous tochastic models [54-59] focuses upon the transitions from X cells to 
Y cells and from Y cells to Z cells. The transition functions determine the probability of transition 
using the recent information about the role of macrophages, IL-1, IL-2 and T helper cells in the 
antibody response [60]. The standard form of the transition function is the probability 
P(Q) = Or~(1 + Q~), 
where Q = A/(qB); A and B are amounts of the appropriate substance or cells, q is the value for 
P(Q) = 1/2 and v is a constant which determines the curvature of the function. The transitions 
which are considered include the transition of mature B cells to proliferating B cells, the transition 
from proliferating B cells to plasma cells, the transition from target T helper cells to proliferating 
T helper cells with concomitant production of IL-2, and the probability that macrophages will 
produce IL-1. Look et al. [60] used discrete-event simulation with the General Purpose Simulation 
System for the IBM 360 to construct a model of the cytotoxic response to malignant lymphoma 
cells. The model includes the circulation of the lymphoma cells to different tissues, the proliferation 
of the lymphoma cells, the activation and proliferation of cytotoxic effector cells and the killing 
of lymphma cells with the cytotoxic ells. Beyond the lag between the antigenic stimulation of 
sensitized lymphocytes and their proliferation, 
dN/dt = kloNe nt, 
where N is the number of tumor cells, I0 is the intial number of cytotoxic lymphocytes, k is the 
rate of tumor cell killing and n is the proliferation rate for the cytotoxic lymphocytes. The stochastic 
aspect of this model is the distribution function which characterizes target cell kill 
F(t') = 1 - N(t')/No, 
where t' is the time since the tumor cell entered aspecific organ, t' = t - to where to is time between 
injection of tumor cells and their entry into a particular organ. The authors describe xperimental 
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verification using ~Cr-labeled tumor cells injected into an animal and detected in the different 
organs as a function of time. 
The mechanism of target cell lysis by cytotoxic T cells has been the subject of detailed 
mathematical treatment [61]. Both a deterministic and a stochastic model were developed and gave 
similar esults. The stochastic model was an application of queueing theory, where arrival time and 
service time show a two-stage model. They advocate a scheme which involves the cytotoxic T cell 
delivering a single, lethal hit upon arrival after which the T cell facilitates the disintegration f the 
target cell, the service. A probability distribution for the target cell disintegration was determined 
[62] and the model tested by comparison with experimental results [63]. 
Another stochastic method is the Monte Carlo method, where the model is constructed in terms 
of probability functions. An iterative computer simulation chooses random numbers which are 
tested against the probability functions to make decisions. For example, a stochastic model of stem 
cell proliferation was constructed using birth and death probabilities for individual cells in analogy 
with population models [64]. Variables were evaluated as a function of time by a Monte Carlo 
method in which random numbers are used with the given probability to decide whether an event 
occurred. 
Summary o f  mathematical modeling methods 
Most of the methods described above involve the use of differential equations in one form or 
another. The equations for the growth of cells are in the form dN/dt  = rN, where N is the number 
of cells and r is the rate at which they are growing. For a population with incoming and outgoing 
cells the form of the equations becomes 
dN/dt  = (r + b - m - d)N, 
where b is the birth rate by which cells enter this population, m is the maturation rate by which 
cells leave this population for a more mature population and d is the death rate. The derivation 
for a particular model depends on the cell types, the assumptions and the level of detail used. For 
example, the detailed cellular kinetic models considered only one cell type and modeled the stages 
of the cell cycle. In the immunological models, where several populations of cells were used 
(including target cells, proliferating cells, effector cells and controlling cells), the details of the cell 
cycle were usually neglected. An exception is Prikrylova's model [59] that describes transitions of 
cells through the cell cycle as controlled by growth factors, T helper cells and T suppressor cells. 
With increased understanding of the molecular events in an immune response, there will be more 
information on the effects of mediators at different stages of the cell cycle. Thus, approaches to 
the description of the cell cycle will become more important to theoretical immunologists. 
Models can be deterministic and the equations exactly describe the biological phemomena, such 
as Bell's ABIGAIL [23-25], or the equations may be stochastic and describe the probability of an 
event. In the latter case, a Monte Carlo method may be used to describe vents for which the 
mechanistic nformation is unavailable. 
Some of the differential equations can be solved analytically, but most are solved through 
computer simulation using numerical methods uch as Euler's or Runga-Kutta. The iterative 
potential of the digital computer makes it possible to use sophisticated random number generators 
for a Monte Carlo simulation or to try many solutions to the traveling salesman problem. The 
cellular kinetic models using difference quations are especially applicable to solution by digital 
computer. 
Among the most useful recent applications in immunology are the use of economic and electrical 
engineering mathematical methods for optimization and description of control networks. Both of 
these methods are highly applicable to immunology using information currently available. For 
example, optimization was used to determine the point in the immune response when lymphoblasts 
stopped proliferating and differentiated into immunoglobulin-producing ells. 
The following sections will review the experimental data which is currently available on the 
differentiation f lymphocytes, raise the crucial questions and suggest theoretical pproaches which 
will aid in the resolution of these questions. 
668 J .R.  LUMB 
LYMPHOCYTE PROGENITOR CELLS 
It is generally assumed that all blood cells originally descend from the pluripotential stem cells 
which are capable of repopulating the blood and lymphoid tissues of an experimental nimal which 
has been lethally irradiated or given equivalent chemical treatment. 
The pluripotential stem cell 
The pluripotential stem cell (PSC) is that cell which is able to regenerate all the bemopoietic cell 
lineages--erythrocytic, myelocytic, granulocytic, lymphocytic and mega-karyocytic/platelet. In an 
adult, the PSCs are found in the bone marrow. When bone marrow cells were i.v. injected into 
a lethally irradiated animal, white nodules appeared in the spleen [65, 66]. It was assumed that these 
nodules were formed from the division of one cell, forming a colony. Since these colonies contained 
all types of bemopoietic cells, it was concluded that there are cells in the bone marrow which are 
pluripotential. Thus, the spleen colony assay became the accepted method for determination of 
PSCs. 
It is generally accepted that these cells have the morphology of atypical, immature lymphoid cells 
[67-73]. Cells with this description make up 1.6-2.0% of human bone marrow cells [74] but 
estimates from spleen colony assays of mouse bone marrow are much lower (0.1-0.7%) [75]. These 
data and that from other work suggest that the cells detected by the spleen colony assay may not 
represent all the pluripotential cells of the bone marrow [76-79]. PSCs are also found in the blood, 
spleen and brain [80, 81]. The understanding of the PSC is severely limited by the current methods. 
The spleen colony assay can only be done in experimental nimals and there is no equivalent 
method to study human PSCs. Thus, it is difficult to obtain accurate stimates of the number of 
PSCs, but 2% of the bone marrow cells is the upper limit of that tissue's contribution. 
Several investigations have shown that in a normal, steady-state condition, most of these cells 
are non-cycling, but they are capable of proliferating when triggered by irradiation, steroids or toxic 
chemicals [82-84]. Lord [85] showed that the non-cycling PSCs are out of cycle in a GO state which 
is located at the end of the GI phase and, therefore, ready to proceed rapidly into DNA synthesis 
upon receiving the proper signals. Since dividing cells are especially vulnerable to destruction by 
various agents uch as irradiation and toxic chemicals, there would be survival benefit in having 
a highly resistant, resting cell population which is capable of restoring all the blood cells. To 
provide a quick response to blood cell destruction, the logical point for the cells to be resting is 
at the end of the G1 phase of the cell cycle. 
Soluble mediators are involved in the regulation of the PSC proliferation. Factors have been 
isolated from the supernatants of normal bone marrow cells which inhibit the PSC proliferation 
[86], and from regenerating bone marrow cell supernatants which stimulate the PSC proliferation 
[87]. Thymus humoral factor will restore the spleen colony-forming cells to thymectomized mice 
[88]. It has also been observed that thymocytes are needed for restoration of the full proliferation 
potential of separated bone marrow cells [75]. Furthermore, it appears that the PSC in mouse bone 
marrow expresses a low level of thyl antigen [89, 90]. The low thyl population represents 0.1% 
of the adult bone marrow cells and contains all the spleen colony-forming cells. The establishment 
of long-term cultures from these cells indicates that they may be self-renewing. This is in contrast 
to the in vivo kinetic data which indicates that the spleen colony-forming cells are non-dividing. 
In summary, the PSCs appear to be a non-cycling population of cells found primarily in the bone 
marrow which is capable of replenishing the blood cell precursors in case of their destruction. 
Current evidence indicates that these cells are not responsible for the renewal of blood cells under 
normal conditions. This conclusion raises several questions in regard to the generation of 
lymphocyte precursors. What cells are responsible for the renewal of lymphocytes? Is there one 
common precursor esponsible for renewing lymphocyte populations? Are the self-renewing cells 
descended from the PSCs? Are the self-renewing cells committed to a particular differentiation 
pathway? 
Theoretical approaches to the progenitor cell problem 
The first mathematical treatment of self-renewing stem cell populations assumed that stem cells 
were capable of an asymmetric division, one that produced another stem cell and a differentiated 
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cell [91, 92]. In order to accommodate he ability of stem cells to recover from irradiation or other 
insults, it was suggested that stem cells were also capable of symmetric division into two stem cells. 
The distribution between the two types of divisions was determined statistically. This approach was 
criticized because there was no experimental evidence of the ability of ceils to divide asymmetrically 
[93]. Therefore, Lajtha [93-95] designed a mathematical model in which the differentiation of a cell 
was a separate vent from cell division. The stem cells were apportioned between available stem 
cells (S,) during a given time interval (n) and the total triggered stem cell stock (T,). Under a 
normal (steady-state) condition, as many cells will be differentiating (d~) as will be triggered to 
divide (t~): 
d~= t,=pS,, 
where p is the proportion differentiating per time interval. If q time intervals equal the total cell 
cycle time, the daughter ceils arising from division are described by 
x. = 2(t._ q). 
Therefore, the available stem cells at time n are calculated by 
S.=S._ l -d ._ , - t ._ ,+x. .  
This system was quite stable and responded to changes in p within two cells cycles. The system 
was also self-protective because the proportion of differentiating cells reached a maximum after 
which further increases in the p value did not increase the number of differentiated cells. 
In order to simulate irradiation, a proportion of the available stem cells were declared sterile 
cells (no longer capable of division) and extra triggered cells were added to compensate for the 
dying cells. After a single dose of irradiation which sterilized 90% of the stem cells, the system 
recovered within 10 cell cycles. Continuous irradiation was also considered. In this case, the number 
of stem cells available only returned to a fraction of the original evel. The results of both of these 
irradiation simulations are similar to experimental data from irradiated animals. However, it was 
necessary to specify the number of extra triggered cells to attain these results. 
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Fig. 1. A schematic representation f the computer simulation THYMS. L, is the number of stem cells 
at time t; L~ is the number of cells in the ith thymus cell population at time t; E is the number of blood 
vessel cells; Sm is the maximum number of stem cells allowed; T E is the total number of blood vessel cells 
in the thymus and T L is the total number of lymphocytes in the thymus. This figure was reproduced with 
permission from Lumb [28]. 
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A regenerating model of the thymus depended upon a stem cell compartment to provide the 
continuous supply of prothymocytes and to allow recovery from irradiation (see Fig. 1, Table 2 
and Refs [26-28]). Each stem cell division was distributed between those producing one stem cell 
and one differentiated cell (S/Sm), and those producing two stem cells (1 - S/Sm), where S was 
the number of stem cells at time t and Sm was the maximum number of stem cells allowed, a 
parameter which was varied. The differential equations which describe the changes in stem cell 
population and differentiated lymphocyte precursors (L) are 
dS/dt = 211 - (S/Sm)]GS 
and 
dL /dt = ( S / Sm)GS, 
where G is the reciprocal of the generation time for the stem cell and L is the differentiated progeny 
of the stem cell. In order to simulate the recovery from irradiation, the number of cells in each 
population was multiplied by the appropriate fraction, depending upon their sensitivity to 
irradiation. The simulated irradiation occurred at a designated time and then the model proceeded 
without any changes. The degeneration f the thymus was simulated by decreasing the Sm value 
as a function of the number of population doublings which had taken place: 
dSm/dt = - DGt Sin, 
where D is the rate of decrease (degeneration parameter) of the maximum number of stem cells; 
D was adjusted until the simulated egeneration was similar to the natural degeneration. 
The results of this simulation, calculated using a digital computer, compared favorably with the 
data for the natural development of the thymus and for recovery from low doses of irradiation. 
However, natural systems showed a slower ecovery from high doses of irradiation than the model 
predicted. It was suggested that the differences resulted from secondary toxic effects of the 
irradiation such as the formation of peroxides and other toxic chemicals. A further efinement of 
the model took these effects into account by using the time since irradiation (t) and the fraction 
of cells surviving that dose of irradiation (F) to decrease the generation time of stem cells after 
irradiation: 
F t = (70[(120 -/)120 -- F]/F, 
where 0 < t > 120 h, Gt is the generation time of stem cells at time t and Go is the unirradiated stem 
cell generation time. By this equation, the generation time of cells immediately following irradiation 
is increased to a maximum value and then decreases gradually to the original value by 120 h after 
irradiation. Because generation time was dependent upon the dose of irradiation via the value of 
F, the toxic effect of increased irradiation doses was simulated. With this refinement the model 
simulated the response to high doses of irradiation more closely [26]. 
One of the most puzzling questions in the study of lymphocyte differentiation is the nature of 
the lymphoid precursor cells. Since the lymphoid populations are restored in lethally irradiated 
animals by the administration of bone marrow cells with markers indicating descendance from 
donor cells, it has been concluded that cells in the bone marrow are capable of differentiating into 
lymphocyte lineage cells [96-98]. However, lymphoid precursor cells derived from PSCs have not 
been directly isolated because of the lack of appropriate markers. Therefore, studies of lymphocyte 
ontogeny invol'/e working backwards from the circulating, mature lymphocytes. 
This is an area where a theoretical treatment may be able to lead researchers tothe identification 
of the lymphocyte precursor. Such a treatment would involve a series of differential equations 
describing the current understanding of the kinetics of known lymphocyte subpopulations. To 
predict he characteristics of the lymphocyte precursor, equations describing precursors according 
to different hypotheses would be added and the number, generation time and percentage in cycle 
of the input cells determined. For example, one hypothesis states that there is a single lymphocyte 
precursor derived from the PSC which generates all the subpopulations of both T- and 
B-lymphocytes. Other hypotheses include the suggestion that two or more precursors are derived 
directly from the PSC, or that the precursors are independent of the PSC. 
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B CELL DIFFERENTIATION 
lmmunoglobulin gene rearrangement 
The genetic events allowing the differentiation f B cells are relatively well-understood [99]. The 
selection of a particular immunoglobulin specificity occurs by the selection of one of a number of 
genes for the variable portion, which, through a series of DNA rearrangement events, is brought 
into the proximity of the genes for the constant portion of the immunoglobulin. The two 
polypeptide chains (light and heavy) of immunoglobulin are coded by separate genes, each of which 
undergoes separate rearrangement events. The pathway of differentiation f B cells is directed by 
these vents. Three regions in the heavy chain gene cluster--the variable region (Vh), the diversity 
region (Dh) and the joining region (Jh)--code for the variable domain of heavy chains. In each 
of these regions, one of a number of genes is selected and the DNA between the two selected genes 
is looped out, bringing the two selected genes in proximity to each other. The Dh and Jh genes 
rearrange first (DJh), and then the Vh gene rearranges with the DJh, forming a VDJh segment 
[100, 101]. Since the region between the Jh genes and the genes for the constant portion of the heavy 
chain is an intervening sequence (IVS), these rearrangements re ult in an immunoglobulin gene 
(VDJh-IVS-Ch) ready for transcription i to hnRNA, the primary transcript. The IVSs are spliced 
out of the hnRNA and the cell is then able to synthesize the mu chain, the most primitive of the 
heavy chains. Once this occurs, the mu chain can be detected in the cytoplasm of the cells (cmu), 
which is the working definition of a pre-B cell. 
The genes for the light chains (either kappa or lambda) are organized in a similar way except 
that they have no diversity regions. A successful rearrangement of the genes for one of the light 
chains (VJ1) then allows the synthesis of the light chain and, finally, the formation of a complete 
immunoglobulin molecule (IgM) (2 light, 2 heavy chains) to be displayed on the surface of the cell. 
The working definition of a B cell is that it has surface immunoglobulin (slg). Thus, at the genetic 
level there are four designations of cells in the B cell differentiation pathway: (1) no immu- 
noglobulin genes rearranged, (2) DJh rearrangement, (3) VDjh rearrangement and (4) both VDJh 
and VJI rearrangements. 
Cell separation and cloning 
While the rearrangement of a cell's DNA allows a relatively certain assignment of the 
differentiation status of the cell, it requires a large number of identical cells from which to isolate 
DNA. There is no current means of isolating cells on the basis of DNA rearrangements. Other 
characteristics of the cells, such as cell size (density) and the presence of cell surface antigens and 
lectin receptors, are used for the separation of lymphocyte subpopulations. Two innovations in 
experimental technology have made it possible to obtain more homogeneous cell populations. First, 
the production of monoclonal antibodies has allowed the identification of many specific antigens 
which are used as markers of cells in different stages of lymphocyte differentiation. The monoclonal 
antibody can then be used to isolate specific subpopulations with the fluorescence-activated cell 
sorter. These two techniques have revolutionized experimental work in cellular immunology 
because it is now possible to obtain homogeneous reagents, both antibodies and cells. Con- 
sequently, in the last 10 years the accumulation of information on lymphocyte differentiation has 
been exponential. 
Once separated the cells can be tested for various functions uch as the ability to restore a 
depleted cell population, the presence of cell surface markers, and cellular kinetic parameters. One 
indication of the normal sequence of cellular differentiation is the chronological order in which the 
cells reappear in an animal that has been depleted of certain populations. 
Alternatively, the immortality of malignant cells can be used to obtain a large number of cells 
with the same characteristics. There are three sources of relevant malignant lymphoid cell lines. 
A number of cell lines have been established from experimentally induced or naturally occurring 
leukemias and lymphomas. Such cell lines can be induced specifically by viral infection of the 
appropriate cells, especially Epstein-Barr virus in humans and Abelson virus in mice. Finally, 
hybridomas that are constructed by fusing normal cells of interest with an immortal cell line have 
the characteristics of both parental cell lines. 
Some normal cell populations such as activated T and B cells can be cloned, providing a large 
672 J.R. LUMB 
number of identical cells. This usually involves the use of growth factors uch as IL-2, the T cell 
growth factor. The cloned cells generally retain their natural functions. 
cmu + Cells 
The bone marrow is assumed to be the location where B cell differentiation takes place in adult 
mammals. However, in the developing embryo, the bone marrow does not contain lymphocytes 
until after birth. The liver seems to be the sources of B cells in the fetus. Thus, both the adult bone 
marrow and the fetal liver have been studied to determine the pathways leading to the mature B 
cell. In both tissues, pre-B cells have been demonstrated by the presence of cmu [102-107]. Large 
pre-B cells are dividing cells and give rise to the small pre-B cells [108, 109], which are non-dividing 
cells [108, 110-112]. The bulk of the evidence indicates that large pre-B cells divide once and are 
not a self-renewing population [107, 113]. 
B220 molecule (14.8 antigen) 
The cell surface molecule B220, which is recognized by the 14.8 monoclonal ntibody, is found 
on pre-B cells and mature B cells [114]. Using a monoclonal antibody against B220 to separate 
pre-B cells, Coffman and Weissman [115] showed that heavy chain genes were rearranged in large 
pre-B cells, but they found no evidence of light chain gene rearrangements in large pre-B cells. 
However, in small pre-B cells they found some light chain genes rearranged. 
Peanut agglutinin 
Another marker used in the study of pre-B cells is the receptor for the non-mitogenic lectin, 
peanut agglutinin (PNA). This marker was first found on some cells in the thymus and peripheral 
lymphoid tissues and thought to be involved in T cell differentiation, but it was also found on pre-B 
cells and some early B cells in adult bone marrow [116, 117] and fetal iver [118-120]. Osmond [121] 
showed that the PNA ÷ bone marrow cells were mostly pre-B cells or cells which had just begun 
to synthesize slg. Some cmu- cells were also agglutinated by PNA. 
There is some evidence that bone marrow precursor cells to the pre-B cells are also PNA +. 
Osmond et al. [122] sorted and cultured PNA ÷ cells from the adult bone marrow and found that 
functional B cells were produced for a longer time than would have been expected if they 
differentiated from the large pre-B cells, which divide only once. It has also been shown that spleen 
colony-forming cells are among the PNA + population [116]. 
Two cell populations were identified in mouse bone marrow which would give rise to B cells in 
the Whitlock-Witte culture system. This system involves the establishment of a layer of bone 
marrow stromal cells to which additional bone marrow cells are added [123]. Under these 
conditions the differentiation f B cells occurs to the exclusion of other cell types. Long-term B 
cell-producing cultures were established from a population of cells which were negative for the B220 
antigen but expressed a low level of thyl antigen. This population contains the spleen colony- 
forming cells and is self-renewing, at least in this culture system. A population without B220 
granulocyte marker, macrophage marker or thyl contained cells which grew for a limited time and 
differentiated into cells with the B220 antigen and surface IgM within 1 week [90]. The suggestion 
is that these B220- cells represent the immediate precursor of the large pre-B cell. In culture, 
25-40% of these cells incorporated tritiated thymidine, indicating that they were dividing cells. 
Kinetic studies have identified a population of cells in the adult bone marrow that precedes the 
large pre-B cell [107]. These pre-B progenitor cells have a labeling index of 35% which is similar 
to the labeling index of the population identified in the Whitlock-Witte culture. The population 
in the culture had a limited lifespan while the kinetically-defined population did appear to be 
self-renewing. 
There is indirect evidence that pre-B progenitor cells are found in the fetal liver during 
development. Pre-B cells (cmu +) are first found in the fetal liver at 16 days gestation, while slg + 
cells are first seen at 19 days [103, 124]. Cells which are capable of producing pre-B cells in culture, 
without he benefit of migrating cells, are found in the fetal liver as early as 11.5 days gestation, 
at the same time as B220 ÷ cells and PNA ÷ cells appear [118-120]. Such cells were not found in 
either the blood or the yolk sac. 
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Depletion studies 
The order of reappearance from irradiation was used to determine the pathway of differentiation. 
The large pre-B cells appeared first, then the small pre-B cells and, finally, the slg ÷ cells [112]. 
Burrows et al. [104] used the treatment with antibody directed against IgM to deplete an animal 
of cells with slgM. They found that the bone marrow is depleted of B cells, but the pre-B cells 
with cmu remain, which will give rise to slg cells. Other animals were treated with cyclo- 
phosphamide which destroys both B and pre-B cells. Again, the same order of appearance was 
observed. It was 3-4 days before the large pre-B cells began to recover; the small pre-B cells 
appeared 1 day later; and, finally, the B cells, which began to recover in another 24 h, were fully 
recovered a total of 9 days after the treatment. In another experiment, the time required for 
complete turnover of the population, called the renewal time, was determined for B cell precursors 
[107]. For small cmu ÷ slg-lymphocytes the renewal time was 48h; for small cmu÷slg ÷
lymphocytes, 96 h; and the cmu-s lg  ÷ are long-lived and, therefore, do not renew in a measurable 
time. 
Pre-B cell differentiation sequence 
A relatively straightforward picture of B cell differentiation emerges from the data discussed 
above (Figs 2 and 3). The earliest detectable B-lymphocyte precursor is found in the fetal liver at 
11-12 days and is B220 ÷, 14.8 + and cmu-  (Table 3). Pre-B cells with demonstrable cmu are 
detected by 16 days gestation, and B cells with slg appear by 19 days gestation in the fetal liver. 
In the adult bone marrow a self-renewing progenitor cell which is low thyl ÷ but negative for 
all other markers differentiates into a B220-, committed pre-B progenitor cell through one or 
several steps (Table 4). These pre-B progenitor cells differentiate into large B220 ÷ PNA ÷ pre-B cells 
with rearranged heavy chain genes. The large pre-B cells proceed through one more division and 
differentiate into small PNA+B220 ÷ cells with cmu. It is at this stage, the small pre-B cell, that 
the light chain gene rearrangement takes place. The resulting synthesis of the light chain allows 
the completion of the IgM. As soon as the IgM is displayed on the surface, the cell fulfils the 
definition of a B cell. 
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Fig. 2. A schematic representation of fetal ymphocyte differentiation. The migration and differentiation 
of lymphocytes in the fetal mouse is shown as a function of gestation, where: + = presence ofmarker; 
- = absence of marker; PNA = receptor for peanut agglutinin; 14.8 = antigen reacting with the mono- 
clonal antibody named 14.8; cmu--mu polypeptide chain found in the cytoplasm; sIg = cell surface 
immunoglobulin; ~t, fl and ~ = polypeptide chains of the T cell antigen receptor; APase = alkaline 
phosphatase; TdT = terminal deoxynucleotidyl t rans ferase .  
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Fig. 3. A schematic representation of B cell differentiation, where: + = presence of marker; 1o = low 
expression of marker; - = absence of marker; T = thyl antigen; P = receptor for peanut agglutinin; 
B = B220 antigen; C = cytoplasmic expression of immunoglobulin mu chain; M = cell surface IgM; 
D = cell surface IgD; L.I. = labeling index; and ? = unknown. The tissue in which the indicated events take 
place is shown at the top of the figure. The turnover time is the time required to completely replace the 
population with new entrants. The circled numbers indicate DNA rearrangement events: (1) the heavy 
chain gene rearrangement occurs between the pre-B progenitor cell and the large pre-B cell; (2) the light 
chain gene rearrangement occurs between the small pre-B cell and the small B cell; and (3) the heavy chain 
switch occurs between the recirculating follicular B cells and the germinal center memory B cells. 
Two observations do not fit this emerging picture. First, only 70% of  the small B cells in the 
bone marrow were the immediate division products of  the pre-B cells. The other 30% were derived 
from a source other than direct differentiation from pre-B cells. The second observation is o f  large 
cmu÷s lg  + cells in the bone marrow which are neither descendants nor precursors of  pre-B cells. 
Figure 3 shows this large B cell with questionable interactions with the subpopulations of  mature 
B cells. The large B cell may represent an intermediate cell in a separate pathway of  B cell 
differentiation that leads to the small B cells not directly descended from small pre-B cells. 
Alternatively, the first small B cell may transform into a large cmu+B cell, perhaps in the process 
of  control l ing the repertoire (see the Control of B Cell Repertoire section). 
However,  the bone marrow is not exclusively a primary lymphoid organ. In fact, it has been 
shown that the bone marrow is responsible for a large proport ion of  serum antibody synthesis [125]. 
Table 3. Fetal liver development 
Incidence (%) 
14.8 +a 
Day of 
gestation PNA + 14.8 + cmu + slg + cmu + slg ÷ 
12 - -  0.2 
14 - -  1.2 
16 19 3.5 0.1 0.2 0.3 <0.1 
19 15 2.2 0.6 4.6 <0.1 
B~ 
al4.8+ ceils wore separated and then tested for cmu or slg 
[124]. 
References: PNA + cells [117]; 14.8 + cells [120]. 
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Table 4. Distribution of bone marrow cells 
Cell type Incidence (%) Number (x  10 -5) Reference No. 
Bone marrow (total) 188 83 
Small lymphocyte 25 46 122, 128 
emu + 3-16 6-27 122, 128 
slg + 7-11 11-19 122, 124, 128 
slg +, cmu + 8.8 13 128 
14.8 + 18 30 124 
14.8 +, cmu + 8.7 14 124 
PNA + 20 33 I 17 
PNA +, emu +, small 11 20 121 
PNA +, cmu +, large 5.7 9.4 122 
TdT +, rat 1.6 128 
human 1.1 183 
PSC, morphology 1.8 74 
human 
tbyl, low 0.1 0.19 90 
CFUs 0.018 0.04 83 
Thus, the large B cells may represent activated B cells and their descendants might be the 30% 
of the small B cells not directly descended from pre-B cells. 
The system is further complicated by the effects of antigen on the differentiation f pre-B cells 
in the bone marrow. The administration f antigen influences the pre-B cell differentiation i  the 
bone marrow [126-128]. Since this activity is dependent upon spleen macrophages and not upon 
those of the bone marrow, there appears to be feedback control of B cell differentiation and 
production. 
Control of B cell repertoire 
The question of control of the development of the B cell repertoire is an extremely important, 
yet unresolved issue in B cell differentiation. How are the potentially self-reactive clones removed? 
The earliest B cell which still has demonstrable cmu appears to be destroyed by interactions with 
the newly formed immunoglobulin receptors on its surface [129, 130]. 
The calculated rate of production of B cells based upon the kinetic data within the bone marrow 
is greater than the rate of appearance of cells in the peripheral tissues or the renewal rate of the 
circulating cells [111,130, 132]. The steady-state rate of migration of lymphocytes from the bone 
marrow into the peripheral tissues is estimated to be 4 x 106cells/day in an adult rat and 
106cells/day in a mouse [7, 133, 134]. However, results vary as to the turnover of circulating 
B-lymphocytes [131,132, 135] so it is difficult to determine whether the export from the bone 
marrow is in excess of that required. This is an area where theoretical treatment could be very 
helpful in resolving an important question. 
Within the bone marrow the number of large pre-B cells is twice that required to produce the 
number of small pre-B cells [111]. If editing were to occur at this level, it could not be via the cell 
surface receptor interaction with antigen because these cells have no slg. A more likely explanation 
for this disparity is this author's uggestion that the division of large pre-B cells is an asymmetric 
one, resulting in one small pre-B cell and another unidentifiable c ll. 
B cell subpopulations 
An early subpopulation of B cells is characterized by its high level of PNA receptors [112] and 
its destruction by antigens or anti-immunoglobulin antibodies when B cells are exposed uring this 
early stage of development [136-138]. These data are interpreted to mean that there is a stage in 
the differentiation rB cells, fight after the immunoglobulin is first displayed on the surface, when 
cells which would react with self-antigens are destroyed. 
With certain antigens, mainly polysaccharides, T helper cells are not required. This response is
called the thymus-independent r sponse and the antigens inducing it are of two types, called TI-1 
and TI-2. TI-1 antigens induce a response in both adult and newborn spleen cells, while newborn 
spleen cells are unresponsive to the TI-2 antigens which induce a substantial response in adult 
spleen cells. Several markers associated with these differences allow subpopulations of B cells to 
be defined. Cells which respond only to TI-2 antigens appear earlier in ontogeny, localize in the 
marginal zone of the spleen, have only IgM on their surface and no IgD and are Lyb-3- and Lyb-5- 
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[139]. The role of the marginal zone B cells in the response to polysaccharide antigens is supported 
by the association of these cells with the type of immunoglobulin subclass found in thymus- 
independent responses [140]. Although the marginal zone B cells are not recirculating cells 
[141-143], they are derived from recirculating cells. Recovery from depletion is considerably 
delayed and is not accelerated by the administration of fetal liver or bone marrow cells, which 
indicates that these cells are far removed from early B cell differentiation steps [144, 145]. 
The majority of the B cells in the lymph and blood are IgM+IgD ÷ recirculating B cells also found 
in the follicles of the spleen and lymph nodes [146, 147]. The recirculating, follicular B cells are 
not direct descendants of progenitors of the marginal zone B cells [147], but the two populations 
seem to be derived from separate lineages of B cells. 
Finally, the subpopulation of B cells found in the germinal centers are distinguishable by the 
expression of a high concentration of PNA receptors, a low level of slgM expression and lack of 
surface IgD [148-150]. These cells bind specific antigen and have undergone the heavy chain switch 
to other classes and subclasses of immunoglobulin. The class of immunoglobulin s defined by the 
type of heavy chain which is combined with either of the two light chains, lambda or kappa. Besides 
the IgM, which has a mu chain, the other classes and subclasses are IgGl, IgG2, IgG3, IgG4, IgA, 
IgD and IgE, which have gamma-1, gamma-2, gamma-3, gamma-4, alpha, delta and epsilon heavy 
chains respectively. The heavy chain gene cluster includes constant genes for all types of heavy 
chains and one set of V, D and J genes. The same VDJh rearrangement which has already occurred 
for the production of the mu chain continues to be used. To switch from mu to any of the other 
heavy chains another DNA rearrangement occurs between the switch region in front of the mu 
chain constant gene and the switch region in front of the other chain constant gene. The mechanism 
of rearrangement appears to be the same as that inducing the initial production of the mu chain 
(see the Immunogiobulin Gene Rearrangements section). This differentiation step in the B cell 
response requires the presence of specific T helper cells and generates the B cells found in germinal 
centers that are responsible for the transfer of memory [151]. 
In summary, the B cell subpopulations include: 
and 
(1) early B cells (IgM ÷, IgD-, PNA ÷, killed by anti-IgM); 
(2) marginal zone B cells (PNA-, IgM ÷, IgD-, Ly5-, sessile); 
(3) follicular B cells (PNA-, IgM ÷, IgD ÷, Ly5 ÷, recirculating); 
(4) germinal center B cells (PNA ÷, IgM l°w, IgD- heavy chain switched, memory. 
Theoretical approaches to the B cell problem 
A model of B cell development with an emphasis on the removal of self-reactive cells has been 
constructed [58]. This model adds the immature B cell (I cell) to the X-Y-Z scheme to simulate 
the control of the repertoire development. Thus, the new scheme is I-X-Y-Z. The equations for 
the concentrations of the three cell types considered (I cells, X cells and Z cells) are 
and 
dI(t ) /dt  = p - [m + Ka(t)] I(t) ,  
dX(t) = ml( t )  - [d + a(t)]X(t)  
dZ(t) = ka(t  - tl )X(t  - tl) - hZ(t) ,  
where I (t) ,  X ( t )  and Z( t )  are the concentrations of I, X and Z cells at time t; p is the rate of 
differentiation of I cells from precursor cells; m is the rate of maturation of I cells into X cells; 
d is the natural rate of death of X cells; h is the death rate for Z cells; a(t) is the rate of elimination 
of X cells by antigen; Ka(t)  is the rate of elimination of I cells by antigen (K = const > 1, which 
indicates that the I cells are more sensitive to elimination by antigen than the X cells); and t~ is 
the time lag between the stimulation of an X cell and the generation of the antibody-producing 
Z cell. This model has been verified by testing against experimental results in chickens [4] and in 
mice [59]. 
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The unresolved questions with regard to B cell differentiation are: 
(1) What are the early phases of B cell differentiation between the thy t°w cell, the 
committed pre-B progenitor cell and the first identifiable cmu ÷ cells? While 
experimental data in this area is limited by the lack of relevant cellular markers, 
a theoretical treatment could be constructed to predict he kinetic parameters of 
intermediate stages from the information available. Such information would be 
helpful to researchers interested in filling these gaps in existing knowledge. 
(2) How do the large cmu+B cells and the other 30% of small B cells fit into the 
B cell differentiation pathway? A mathematical model of the bone marrow is 
needed which would include the major B cell differentiation pathway, events 
leading to antibody synthesis in the bone marrow and some consideration of 
feedback control by an ongoing immune response in the spleen. The model 
would consist of a series of differential equations combining the ideas of Bell 
[23-25], Lumb [26-28] and Prikrylova [59]. The three hypotheses suggested to 
account for the large cmu+B cells and the other 30% of small B cells could be 
tested with this model. 
(3) How is the B cell repertoire controlled to eliminate self-reactive B cells? Is there 
a threshold level of binding of self-antigens above which the system rejects? It 
appears that perhaps half of the B cells are eliminated in the bone marrow. Is 
that adequate to eliminate the potential self-reactive c lls? Where and when does 
the elimination occur? Because the actual binding of self-antigens and foreign 
antigens is completely dependent upon the molecular structures of the antigen 
and the antibody, and because there are very sophisticated molecular structure 
programs available, it seems that the questions of how much binding is too much 
and whether the elimination of half the B cells is adequate might best be 
approached at the molecular level. Using estimates of the number of different 
antibodies derived from the numbers of variable genes, along with estimates of 
the number of possible antigenic structures (considering the specificity limits of 
self vs foreign) and extrapolations from known structures of antigen-antibody 
complexes, it should be possible to estimate the number of self-reactive B cells 
which could be produced. Either the traveling salesman iterative method or 
optimization methods might also be applied to determine the optimum position 
between the conditions of auto-immunity and of too little anti-foreign immunity. 
PROTHYMOCYTES AND pre-T CELLS 
The study of precursors to T cells has developed in a different way from that of B cell precursors. 
While there was no functionally defined marker such as cmu, the thymus has provided a known 
organ devoted almost exclusively to the differentiation of T cells. The terms prothymocyte and 
pre-T cell have different experimental definitions. A prothymocyte is a cell which will migrate to 
the thymus and repopulate the lymphoid elements of that organ. A pre-T cell is one that will 
respond to treatment with differentiating agents, such as thymic hormones, with the production 
of T cell markers, such as thy 1 in mice or T3 in humans. In the adult, steady-state condition, the 
prothymocytes migrate to the thymus from the bone marrow, where they make up only a very small 
proportion of the lymphoid cells. Bone marrow cells migrating to the thymus have been determined 
[152]. They lack thyl and Lyt antigens, are separated from the cells of the B cell lineage, and 
constitute 0.1% of the bone marrow cells. During fetal development, he thymus is the first 
lymphoid organ to contain lymphocytic lineage cells, which migrate to the thymus from the yolk 
sac [153-156]. 
T cell antigen receptor 
The recently discovered T cell antigen receptor allows more precise definition of the steps of 
T cell differentiation [157-162]. As with immunoglobulin, the genes for the T cell receptor have 
the V-D-J -C organization and the differentiation in the thymus involves rearrangement to
C.A.M.W.A. 14/9-12~ 
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expressible genes with the selection of particular V, D and J segments [163]. Three types of 
polypeptide chains have been identified: alpha, beta and gamma. In mature T cells, the T cell 
receptor is composed of one alpha and one beta chain. The gamma chain is thought to be involved 
in early T cell development [164, 165]. In keeping with the analogy of the T cell receptor gene 
rearrangements to that of the immunoglobulin genes, three distinct populations of thymocytes can 
be identified: (1) those with germline configuration for both the alpha and beta T cell receptor 
genes, called pro-T cells (for progenitor T cells); (2) those with germline alpha genes and 
rearranged/expressed beta genes, called pre-T cells; and (3) those with both alpha and beta chain 
genes rearranged/expressed, called T cells [166, 167]. Expression of the gamma chain gene appears 
first in the fetal thymus at 14 days and then decreases rapidly by the 17th day of gestation when 
the beta and alpha chain genes are expressed [168, 169]. 
Terminal deoxynucleotidyl transferase 
The first identified marker of pre-T cells was the enzyme terminal deoxynucleotide transferase 
(TdT) which was associated with lymphoid bone marrow cells and approx. 75% of thymus cells 
[170-172]. TdT ÷ cells first appear in the mouse fetal thymus at 17 days (4 days before birth) and 
at birth in the spleen and bone marrow [173]. Transient populations of TdT + cells are also seen 
in the liver, lung and peripheral blood in the first 10-14 days after birth [174]. The TdT + cells are 
present in the normal mouse spleen only up to 6 weeks of age. That these cells include pre-T cells 
is evidenced by two findings: half of the TdT+thyl - cells from normal mouse bone marrow have 
been shown to express thyl after incubation with thymic hormones [175-177]; and populations 
enriched for prothymocyte activity are also enriched for TdT + cells [178]. Thymic hormones which 
act early in T cell differentiation will induce TdT activity in spleen cells from athymic (nude) mice 
[179, 180]. TdT activity in normal thymocytes is decreased by a T cell differentiating factor isolated 
from blood, which acts later in T cell differentiation, and by retinoic acid, a general differentiation 
inducer [181]. There is also evidence that TdT is a marker of human bone marrow prothymocytes 
[182-184]. 
Thus, it appears that the TdT ÷ cell represents a stage of T cell differentiation i termediate 
between the PSC and the mature T cell [185, 186]. However, TdT is not limited to T cell 
differentiation and is also found in pre-B cells [176, 187]. In addition, it has been shown that a 
majority of the cells capable of repopulating the thymus (75%) are found in a population which 
had been depleted of TdT ÷ cells [190]. Thus, while some prothymocytes are TdT +, not all are. 
Peanut agglutinin 
The PNA receptor in a useful marker in T cell differentiation because itbinds to most lymphocyte 
precursors and immature lymphocytes, but not to mature T cells [188]. Since agglutination is a 
convenient separation technique, most marker systems have been combined with PNA for a more 
detailed analysis. The earliest PNA + cells reported were in the yolk sac at l0 days gestation [189]. 
These cells had the morphology of an undifferentiated cell, but compared to cells with euchromatic 
nuclei. PNA ÷ cells appear in the fetal liver (11 days) and the fetal thymus (14 days) at the same 
time as the first functional lymphocyte precursors [119]. In the adult bone marrow, there is evidence 
that the PSC [120], the large pre-B progenitor cells, all pre-B cells, and early B cells [122] are all 
PNA ÷. In the thymus, PNA agglutination is used to separate the immature cells, assumed to be 
found in the cortex, from the mature, cortisone-resistant T cells, and can be used with other 
markers to identify subsets of thymocytes [191,192]. This will be discussed in more detail ater in 
the section intrathymic T Cell Differentiation. 
The receptor for PN6 is a specific sugar moiety which is on the outer surface of the cells. It seems 
that this receptor appears early in the differentiation sequence leading to mature lymphocytes. 
Mature B cells actually lose the receptor while mature T cells merely cover it up with sialic acid: 
Therefore, treatment with an enzyme that hydrolyzes sialic acid (neuraminidase) transforms mature 
T cells from PNA- to PNA + [117]. 
Other markers of pre-T cells 
A placental isozyme of alkaline phosphatase is found on fetal thymocytes up to 17 days gestation 
[193-196]. Alkaline phosphatase is also found on a few bone marrow cells (< 1%), spleen cells 
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(marginal zone) and some activated B and T cells [197, 198]. There is also evidence by electron 
microscopy that a few subcapsular cells in the adult thymus are alkaline phosphatase ÷ [199]. The 
significance of this marker is not yet determined although the distribution among cell types uggests 
alkaline phosphatase may be useful in the isolation of early lymphocyte progenitor cells. 
FT-1 and FT-2 are recently discovered fetal thymus markers which are present in the developing 
thymus up to 17 days gestation [200, 201]. Unlike other markers described, these are exclusively 
localized in the fetal thymus and on leukemia cells. 
Using anti-mouse brain antibody, it was discovered that a neutral glycolipid (asialo GMI) was 
on fetal thymocytes but not on adult thymocytes or mature, circulating T cells [202, 203]. 
Growth factors 
IL-2 functions as the T cell growth factor. In order to respond to this growth factor, cells must 
carry specific IL-2 receptors on their surface. It was found that the most immature thymocytes 
(Ly-2-, L3T4-) and fetal thymocytes at14 days gestation have IL-2 receptors but do not proliferate 
in response to IL-2 unless otherwise stimulated [204-206]. 
Lymphocyte precursors in the human bone marrow were identified by their response to IL-2 or 
to thymic hormones [207]. The IL-2 responsive cells already expressed both the IL-2 receptor and 
the T8 human cytotoxic ell marker prior to exposure to IL-2, while the thymic hormone-dependent 
population expressed the T4 human helper cell marker. 
The production of IL-2 is generally associated with helper T cells; however, in fetal organ culture, 
IL-2 production and the ability to develop into cytolytic ells were both found in both Lyt2 ÷ and 
Lyt2- populations [208]. This suggests that the Lyt2 marker may have a different meaning in fetal 
lymphocytes. This is also shown with the mature marker, thyl, which is found early in fetal 
development, prior to the development of any other mature T cell functions (Table 5). 
Role of fetal liver in thymus development 
The extent o which the fetal liver is involved in thymic differentiation has been in dispute. 
Initially, PNA was thought o be a thymus-specific marker so that the presence of PNA ÷ cells in 
the fetal iver of mice was taken as evidence of involvement in thymic development. However, since 
the PNA + cells in the fetal liver could be B cell precursors, that conclusion was less definite. In 
humans there is more direct evidence of fetal liver involvement in thymus development [209, 210]. 
Gene products of a gene cluster linked to the IgH-1 gene have been shown to be associated with 
thymocyte development and are also found in the fetal liver [211]. 
Summary of fetal thymus development 
The cell distribution during development ofthe fetal thymus is shown in Table 5. There are three 
phases in the development of the thymus, as illustrated in Fig. 2. In phase 1, cells are produced 
in the mouse yolk sac and migrate to the thymus at 14 days gestation. In phase 2 (14-16 day fetal 
thymus), cells are identified by several markers (FT-1, FT-2, asialo GM1, alkaline phosphatase) 
Table 5. Fetal thymus development 
Number of Incidence (%) 
Days of  lymphoid 
gestation cells" TCR b APase ¢ GM1 +d TdT  ÷c thyl +f Lyl +r Lyt2 +f 
13 1 × 104 - ND 68 0 39 36 10 
16 3 x 105 y + 17 84 80 62 
17 6× l0 s ),,fl - 2.0 
18 9 × 105 ~, B - 2.5 
19 1 × 10 6 0~, fl -- 8 4.5 95 95 85 
20 3 X 106 ~, p -- 8.0 
Birth 5 × l0  6 ~, fl - 26 
1 Week 5 x 107 ~, fl - 48 
Adult 2 x 108 ct, p +/_s  5 65 95 95 83 
' Lumb [26-28]. 
b'l" cell antigen receptor chain expressed/rearranged [164, 165, 168, 169]. 
CLumb [194, 195]; Floyd and Lumb [196]. 
dH~bu and Okumura [202]. 
CGregoire et aL [175]. 
fMathieson and Fowlkes [219]. 
SGotiinet [199], a few subeapsular APase + cells seen only by EM. 
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and by expression of the gamma T cell receptors gene. In phase 3 (17-20 day fetal thymus), cells 
are TdT +, and have alpha and beta T cell receptor genes rearranged/expressed, but FT-1, FT-2 
and alkaline phosphatase have essentially disappeared. In phase 4 (birth-adult), the bone marrow 
has begun to function and provide thymic precursor cells. 
Kinetics studies of bone marrow prothymocytes 
Studies of regeneration from irradiation using bone marrow cells have provided cellular kinetic 
information about prothymocytes. Bone marrow that is in the process of regenerating has fewer 
prothymocytes than normal bone marrow, suggesting that the prothymocytes, or the cells which 
produce them, are diverted to another function during regeneration [212]. Another remarkable 
finding was that the repopulation of the thymus which had been irradiated showed a gated 
phenomenon; i.e. up to a level of 450 rad of irradiation o donor bone marrow cells were found 
repopulating the thymus. However, with doses of />450 rad, the thymus was repopulated with 
numbers of donor cells that were proportional to dose [190]. Thus, the putative prothymocyte is 
contained in a population of host cells that survives irradiation of <450 rad. 
In summary, cells capable of repopulating the thymus are found in the bone marrow. Some of 
these cells (approx. 3 x 105 in mice) are TdT- and the rest constitute half the TdT + bone marrow 
cell population, approx. 105 cells. 
Theoretical approaches to the pre-T cell problem 
The only theoretical treatment of the pre-T cell problem is THYMS (cf. Table 2, Fig. 1 and Refs 
[26-28]). This model has been described above (under Theoretical Approaches to the Progenitor Cell 
Problem). One of the results from this work is the calculation that 105 cells must enter the mouse 
thymus each day to maintain the observed steady-state conditions. 
Clearly, this area suffers from a lack of dependable cell markers. In the fetal thymus 
development, the markers FT-1, FT-2 and asialo GM 1 are useful, but are not described in the bone 
marrow. There are a few alkaline phosphatase ÷ cells in the bone marrow, but no studies have been 
done to determine if these cells are prothymocytes or prothymocyte progenitors. Since the TdT ÷ 
cells are divided evenly between those which are prothymocytes and those with B cell lineage 
markers, the immediate precursor of these cells may be a common one between the two lineages. 
In the fetal thymus, the immediate precursor of the TdT ÷ cell was alkaline phosphatase +. This 
marker should be exploited in the bone marrow. 
The unresolved questions concerning the pre-T cell/prothymocyte ar : What is the nature of the 
prothymocyte? What is the sequence of differentiation leading up to the prothymocyte? Is there 
a common precursor cell with the B cell differentiation pathway? The prothymocyte should be 
included in the model of the bone marrow described above (under Theoretical Approaches to the 
B Cell Problem). An expanded model could be used to predict he characteristics of the progenitor 
cells and to test alternative hypotheses ofprothymocyte differentiation. Because xperimental data 
is lacking in this area, a theoretical pproach can yield significant directions for laboratory research. 
INTRATHYMIC T CELL DIFFERENTIATION 
The basic function of the thymus is the differentiation f T cells. Cell surface markers define two 
major subpopulations of mature, circulating T cells with distinct functions [213]. Helper and 
inducer T cells have the L3T4 marker in mice and the T4 marker in humans. Cytotoxic and 
suppressor T cells have the Lyt-2 marker in mice and the T8 marker in humans. Most of the 
experimental work has been done in mice so that system of nomenclature will be used. 
The thymus is composed of an outer capsule, a cortex that contains 850 of the lymphocytes 
and a medulla that contains the other 15%. Generally, the cortical ymphocytes are less mature 
than those in the medulla. Treatment with hydrocortisone d stroys 950 of the cells of the thymus, 
all of the cortical cells and two-thirds of the medullar cells, but not the cells which will initiate a 
graft-vs-host reaction when injected into a non-responding host. Blomgren and Andersson [214] 
studied the recovery from cortisone destruction of 950 of the cells in the thymus. The 
cortisone-sensitive cells were the short-lived cells, and therefore, the cortisone selected for the 
long-lived lymphocytes, which were shown to contain all the immunocompetent lymphocytes o!
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the thymus capable of mounting a graft-vs-host reaction. Borum [215] demonstrated that small 
thymocytes arise from the mitotic division of large lymphocyte in the thymus. 
Using different marker systems, at least six subpopulations have been identified in the thymus 
[216--219]. There is no general agreement on a single explanation for all the results. The relevant 
questions are: (1) How many different hymic precursor cells migrate from the bone marrow and 
what is the identity of each? (2) How many different lineages mature in the thymus? (3) What are 
the identities of the cells at different stages in the pathway of differentiation for each lineage? (4) 
What are the identities of the thymus emigrant cells? 
thyl 
The marker which is associated with all mature T cells in mice is thyl. In fact, that is the working 
definition of a mature, circulating T cell. In the thymus, two subpopulations of cells can be 
distinguished by the amount of thyl and H-2 antigen they carry on their surface. Generally, the 
immature cortical cells have high thyl and low H-2, while medullary cells have low thyl and high 
H-2 [220, 221]. 
Ly antigens 
Ly antigens are markers in the mouse confined to lymphocyte lineages and are found on both 
B and T cells, while Lyt antigens are found only on T cells and Lyb antigens are found only on 
B cells. Specific antigens are designated by numbers. Lyl was originally thought o be a specific 
marker of T helper cells, but it is now known that Lyl is on some B cells [222, 223], and a more 
specific marker for T helper cells in mice, called L3T4, was developed [224]. Lyt2 and Lyt3 are 
generally found together on cytotoxic and suppressor T cells. 
Recent results delineating thymic subsets using Ly antigens have been reviewed [213, 219, 225]. 
In addition to the mature phenotypes, Lyt24 L3T4- and Lyt2- L3T4 4, both double negative and 
double positive cells exist in the thymus. The subcapsular population with low levels of Ly I (called 
dLyl for dull Lyl), which is also Ly2- L3T4-, has been shown to transiently repopulate the thymus 
after irradiation [225]. 
Six thymic subsets have been identified by localization of Ly 1, Lyt2, thy 1 and T200 (a cell surface 
molecule in the same family as B220) [226]. The two major populations were the cortical cells 
with high thyl, high T200, high Lyt2 and variable Lyl, and the medullary population with low 
thy 1, high Ly 1 and no Lyt2. A minor population of medullary cells had low thy 1, moderate T200, 
high Lyl and high Lyt2. Three subcapsular populations were found: (1) one that was negative for 
all markers tested; (2) one that was thyl 4, but negative for all others; and (3) one that was thyl 4, 
T2004, Lyl -  and Lyt2-. Depending upon the relative sensitivities of the assays involved, these 
three populations could all be included in the dLyl population of Fowlkes et al. [227]. 
Another study asked the question, "Are there any mature, medullary cells in the outer cortex?" 
[228]. The outer cortex was labeled by dipping in dye and the stained cells analyzed. Neither cells 
capable of responding in functional assays nor cells of the complete medullary phenotype were 
found. 
Peanut agglutinin 
PNA has been used to separate the cortical cells (PNA 4) from the medullary cells (PNA-) of 
the thymus. At the time of birth 85% of the thymus cells are PNA ÷ [188]. The PNA 4 cells have 
the same phenotype as the majority cortisone-sensitive, cortical thymocyte (high thyl, low H-2) 
and are unable to participate in immune reactions [228]. The antigen Ly6.2 allowed further 
identification of thymic subsets of PNA + and PNA- cells [191]. The PNA 4, Ly6.2 ÷ cell population 
contained suppressor cells; the PNA-, Ly6.2 ÷ population contained helper cells; and the PNA ÷, 
Ly6.2- population contained cells of the immature phenotype, Lyt123 ÷. 
Terminal deoxynucleotidyl transferase 
TdT was first demonstrated in the calf thymus as an unusual DNA synthesizing enzyme, one 
which did not use a template, but added nucleotides in a random fashion [170]. PNA was used 
to separate cells to identify thymocyte subpopulations u ing TdT [192]. It was not surprising that 
the PNA ÷ cell population included the TdT ÷ cells, but it was surprising that TdT and TL could 
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be induced in some of the PNA- cells by incubation with one of the thymic hormones. This raises 
two possibilities, that an immature cell population is among the PNA- cell populations, or that 
the mature PNA- cells remain capable of responding to thymic hormone influences out of the 
microenvironmental context of the thymus. Goldschneider et al. [218] examined proliferating 
cortical and medullary thymus cells by applying tritiated thymidine to the outside of the thymus 
and by systematic njection. They found dividing cells in the low and high thyl thymic subsets, 
and that all the TdT ÷ thyl low dividing cells are in the cortex, while two-thirds of the TdT- thyl 
low cells are in the medulla and also have high levels of H-2 antigen. 
Thymic education (MHC restriction) 
The differentiation of T cells is made more complex by the restrictions placed upon T cell 
function. The MHC is a gene complex which codes for a number of cell surface molecules, identified 
by their immunological properties as antigens, initially involved in the determination f tissue 
transplantation compatibility. In the mouse, this gene complex is called H-2 and in the human, 
HLA. Now it is clear that the several gene products of the MHC are responsible for control of 
the immune response. One of these is the restriction of T cell response to antigens presented in 
the context of self MHC determinants. The T cell antigen receptor now isolated has a dual 
specificity; i.e. it is specific for a particular foreign and for the appropriate self MHC antigen. This 
is further complicated by the existence of two classes of MHC molecules, and the fact that different 
subpopulations of T cells are restricted by particular classes. For example, cytotoxic T cells respond 
only to foreign antigens presented by cells with same class I MHC molecules as the T cell. Helper 
T cells are restricted to foreign antigens een in the context of class II MHC molecules. 
Helper T cells are restricted to recognition of foreign antigens in the context of the Ia MHC 
gene product. Ia ÷ dendritic reticular cells (part of the meshwork in which the thymocytes lie) 
from the bone marrow are found in the medulla of the thymus [229]. Using antiserum to deplete 
an animal of Ia ÷ cells prevents the development of helper phenotype cells (MHC class II 
restricted), but not the MHC class I restricted cytotoxic cells [230-234]. The role of these 
bone-marrow-derived Ia ÷accessory cells is further shown by the observation that when fetal liver 
cells were used to reconstitute a lethally irradiated animal instead of adult bone marrow, the MHC 
restriction is that of the host only, never the donor [235]. Since the cells presumably responsible 
for thymic education, especially in regard to MHC class II restriction, come from the bone marrow 
which does not begin to function until after birth, one could conclude that the Ia ÷ accessory cells 
may also be transferred in the bone marrow. Other mechanisms for thymic education must be 
present in the fetal thymus. In that context, it has been shown that the gamma T cell receptor gene 
expression is not required for MHC class II restricted helper T cells [236]. 
Non-thymic T cell development 
Even the assumption that T cells are all differentiated in the thymus is in question. The nude 
mouse, which has a congenital lack of a thymus, has some minimal development ofT cell function 
[237, 238]. 
The marker thyl has been used as the definition of a mature T cell. There is question as to both 
the necessary and sufficient nature of this marker to T cell function. It has already been mentioned 
that thyl cells are found early in the fetal liver prior to the development of T cell function, and 
therefore, are not a sufficient condition for mature T cell function. That thyl is not a necessary 
condition is illustrated by recent work showing that natural killer cells have rearranged and 
expressed beta T cell receptor genes [239]. Natural killer (NK) cells carry neither immunoglobulin 
nor thyl markers and, therefore, did not fit the definitions of antigen specific lymphocytes. 
However, they do kill tumor cells preferentially, sparing normal cells. It will be important to 
determine if the alpha or gamma T cell receptor or immunoglobulin genes are rearranged in NK 
cells. 
Summary of T cell differentiation 
The thymus is the first lymphoid tissue to develop. Lymphoid precursor cells migrate to the 
mouse fetal thymus by 14 days gestation and by birth, before the bone marrow develops, all the 
subpopulations are represented. In the adult, thymic precursor cells migrate from the bone marrow. 
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The subcapsular cells (dLy 1) appear to be the bone-marrow-derived emigrants because they include 
population(s) which will repopulate the thymus transiently in only one wave after depletion. 
However, there is no evidence for a self-renewing cell population in the thymus. The two major 
cell populations in the thymus are the major cortex cells (dividing: high thyl, low H-2, TdT ÷, 
PNA ÷, Lyt2 ÷, L3T4 ÷) the major medulla cells (resting: low thyl, high H-2, TdT-, PNA- and 
either Lyt2 ÷ or L3T.4 + but not both). Careful studies employing several markers have shown 
several more subpopulations. The distribution of cell subpopulations in the thymus is shown in 
Table 6. Cells which migrate from the thymus to the peripheral tissues have the phenotype of the 
medullar cells. The pathway(s) of differentiation through the thymus is(are) not fully understood 
at this time. In fact, the questions, (1) How many separate pathways exist in the thymus? and (2) 
Where do they diverge? are matters of considerable controversy. Other questions which must be 
resolved with quantitative information include: (3) How many cells of each type are produced? (4) 
At what rate do they emigrate? and (5) How many cells at each stage die in the thymus or elsewhere? 
Control of T cell repertoire 
As with B cells, one of the most important issues is the control of the development of the T cell 
repertoire. In order to account for an editing step in which self-reactive T cells are destroyed, 
immunologists generally assume that the great majority of cells produced ie in the thymus without 
emigrating. The earliest citation for this conclusion is Miller and Osoba [240]. In this review, the 
authors gave two pieces of evidence that thymocytes did not emigrate. One was an experiment in 
which animals, implanted with 20 thymuses, showed no increase in the level of circulating small 
lymphocytes. No consideration was given to host controls of cellular proliferation that would be 
likely to prevent he expected over-production f T cells. The other evidence given was a labeling 
experiment [241] which was later shown to have been flawed [242, 243]. 
Everett et al. [8] calculated the rate at which small thymocytes were replaced to be 1.7%/h. In 
60 h, enough cells were produced to replace all the cells in the thymus or to replace all those in 
the peripheral lymphoid tissues. They concluded that the 95% short-lived thymocytes must die 
either in the thymus or after migrating into the peripheral tissues, and that the remaining 5% of 
the produced cells, the long-lived lymphocytes, were produced at a rate that could account for the 
daily increase in the number of long-lived lymphocytes in the lymph nodes, spleen, Peyer's patches, 
lymph and spleen. 
A number of studies have been done to assess the rate of cell death in the thymus. Michaelke 
et al. [244] studied the cellular production of the newborn mouse thymus and found that one-third 
Table 6. Intrathymic ell distribution in mice 
Incidence Labeling 
Subpopulation (%) index (%) Reference No. 
Thymocytes (all) 100 8-11 218,225 
small 85 0.6 27, 225 
large 15 43 27, 225 
PNA + 87 12 225 
small 72 0. I 225 
large 15 39 225 
PNA- 13 3.9 225 
Ly2 + L3T4 + 80 225 
Ly2- L3T4 + I 1 225 
Ly2 + L3T4- 4 225 
Ly2 L3T4- 4 31 225 
B2A2- 3 1.8 225 
thyl + (all) 98 117 
high thyl 85 9.5 218 
low thyl 15 6.4 218 
H-2 (all) 100 218 
low H-2 78 218 
high H-2 22 218 
high H-2, high thyl 8 218 
high H-2, low thyl 14 218 
TdT + 70 218 
high thyl 62 218 
low thyl I 218 
high thyl, high H-2 5 218 
low thyl, high H-2 < 1 218 
PNA + 35 192 
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Table 7. Cell distribution in peripheral lymphoid tissues 
Incidence (%) 
Recent emigrants* 
Thoracic Lymph 
Cell type Blood duct Spleen nodes Spleen Lymph nodes 
Long-lived b 66 90 
slg +b 17 20 36 30 
thyl +b 80 80 25 70 
Ly2 + L3T4 +" 3 3 0 0 
Ly2- L3T4 +a 17 40 6.8 7.0 
Ly2 + L3T4 -~ 8 20 3.4 4.0 
Ly2- L3T4 -a 72 37 0.8 0.4 
'Incidence in the spleen and lymph nodes of cells which migrated from the thymus 
recently and Ly2, L3T4 data [225]. 
bBell [277]. 
of the cells were lost per day. Since they found little evidence of cell death, they suggested that 
the cells were lost by emigration. This is similar to the turnover rate of 1.7%/h (36%/day) 
calculated by Everett and Tyler [7]. However, this tremendous output from the thymus is 
inconsistent with the well-established observation that most of the recirculating pool of lympho- 
cytes is long-lived (Table 7). According to calculations by Bryant [245], only 2.5% of the cells 
produced by the thymus contribute to the long-lived lymphocyte pool. These data all support he 
notion of an excess cellular production in the thymus. 
The obvious question, then, is, what happens to those cells produced in the thymus? Do the cells 
die in the thymus or do they emigrate and then die somewhere else? The histological appearance 
of early dying cells is one of pyknosis, the dark staining of the chromatin. Since this is easily 
confused with the appearance ofearly dividing cells, estimates of pyknosis in the thymus vary from 
0.025% in the cortex and 0.073% in the medulla [244, 245] to 0.7% in the whole thymus [247]. 
The conclusions from these data also vary from the suggestion that the excess cells must emigrate 
[244, 246] to the conclusion that the pyknotic rate is almost as high as the mitotic rate as determined 
by histology [247]. 
Two studies estimated the proportion of blast cells which incorporate label but do not proceed 
into mitosis to be 17% [246] and 25% [245]. The reutilization of tritiated thymidine released from 
the dying thymocytes i  a problem in these studies, tritiated thymidine has been used along with 
labeled iododeoxyuridine which is not reutilized [248]. It was estimated that 19-28% of the labeled 
thymidine was reused in the thymus, indicating that at least some of the blast cells do die in the 
thymus. However, this amount of cell death would be already reflected in the results of kinetic 
studies which determine the production of small, non-dividing lymphocytes. It is the over- 
production of the mature cells which is in question. 
Studies of the comparative counts of lymphocytes in blood prior to entrance into the thymus 
and following exit from the thymus give a more direct accounting of how many cells actually 
emigrate from the thymus. Different results are obtained epending upon the experimental nimal 
used. In guinea pigs, only a small increase in cells was shown, not enough to account for the 
over-production f lymphocytes in the thymus [249-251]. In mice and rats, studies have shown an 
increase in the number of lymphocytes/mm 3 ofblood that is sufficient to account for the emigration 
of all the lymphocytes produced in the thymus [252]. The difference between species was not 
surprising because there is histological evidence of cell death in the guinea pig thymus [252]. Guinea 
pigs have large cysts in their thymic medulla which contain numbers of degenerating leukocytes, 
while rats and mice have very few such structures until older age when the thymus involutes. The 
other studies which showed little evidence for cell death in the thymus involved either rats or mice. 
Thus, the generally accepted notion that the majority of the cells die in the thymus is probably 
wrong, at least for rats and mice, which have been used for most the studies on T cell differentiation. 
That leaves unanswered the question of what happens to all those cells produced by the thymus. 
Scollay et al. [253] labeled thymocytes by an intrathymic injection of fluorescein and then detected 
fluorescent cells in the tissues. They calculated that 1% of total thymus cells appear in the periphery 
each day. Again, they did not show morphologic evidence of dying cells in the thymus, but they 
did observe an accumulation of fluorescent material in the lungs. Using both the reutilized tritiated 
thymidine and the labeled iododeoxyuridine, which is not reutilized, the cellular migration from 
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the thymus was assessed in the peripheral organs [248]. The intestine and bone marrow showed 
the most reutilization of labeled thymidine, indicating that cells had died in these organs. However, 
lungs were not tested in this study. It is very difficult to detect all the lymphoid cells in an entire 
animal by assaying selected organs. It is known that epithelial tissues uch as the skin and the lining 
of the intestines contain lymphocytes. 
The real question of the control of repertoire development is a qualitative one. What are the 
specificities of the T, or B cells, which die? This question has not been addressed experimentally 
but perhaps a theoretical approach might lead the way. Specific methods are described above 
(under Theoretical Approaches to the B Cell Problem). 
Theoretical approaches to the thymus problem 
Leblond and Sainte-Marie [254] were the first to construct models of the cellular kinetics of the 
thymus. At that time, thymocytes were divided into three size categories, mall, medium and large, 
and it was believed that the sequence of differentiation proceeded from the largest hrough to the 
smallest. These researchers determined the incidence and mitotic index of cells in each size category 
in both the cortex and the medulla. They compared the experimental data to theoretical values 
calculated using models which varied the number of cell divisions in each category. The model 
which fit the data for the thymic cortex the best was one in which the large lymphocytes divided 
four times, the medium lymphocytes twice and the small lymphocytes were exported. Both the 
cortex and medulla showed the same mitotic index for each size category except hat the cell 
distribution was skewed heavily toward the small lymphocytes. They concluded that the additional 
small lymphocytes in the medulla, which could not be accounted for by the division of large and 
medium lymphocytes, were migrants from the cortex. They further reasoned that, since they 
observed iapedesis of lymphocytes (cells moving across blood vessel walls) in the medulla, and 
not in the cortex, that the cortical lymphocytes must be exported through the medulla to the 
periphery. 
The nucleolar morphology and the uptake of tritiated thymidine was used to determine cellular 
kinetic parameters in the thymus [255]. Since two nucleolar morphologies, dense nucleoli and 
trabecular nucleoli, were correlated with the uptake of tritiated thymidine, they were used to 
identify proliferating cells. Since nucleoli structures associated with proliferating cells, and those 
associated with resting cells, were found in all three size categories, all kinetic parameters were 
defined for each morphological cell type. The model they designed showed proliferating and 
non-proliferating compartments for each morphological category of thymus cells. The cellular 
transitions are: (1) from the large, proliferating lymphoblasts o non-dividing cells with the same 
morphology; (2) from large proliferating lymphoblasts o proliferating, medium prolymphocytes; 
(3) from proliferating, medium prolymphocytes to non-dividing cells with the same morphology; 
and (4) from proliferating, medium lymphocytes to the mature, non-dividing, small lymphocytes. 
Transitions (1) and (3) are hypothetically reversible and the non-dividing cells may, hypothetically, 
transist from lymphoblast to prolymphocyte o the mature lymphocyte. Since there is much more 
detailed information ow available from studies with markers, theoretical treatments such as this 
one may now be brought up to date. 
Prothero and Tyler [256] used the analogy of specific feedback circuitry to construct a model 
of thymocyte proliferation. They assume that cells enter and leave G1 at random and proceed 
through' S, G2 and M sequentially with a defined flux time. Flow within and between sequential 
compartments is defined by 
S l ( t )=S i_ l ( t  -- 1) 
and similar recursive xpressions. The flow between a sequential compartment (M) and a stochastic 
compartment (GI) is described by the differential equation 
dx/dt = Kf(t) - g(.t), 
where dx/dl  is the rate of labeling the G1 compartment, f ( t )  is the fraction of labeled cells in M, 
g(t) is the fraction of labeled cells in G1 at time t and K is stated to be the rate of flux for G1. 
However, I believe that K is the flux rate for M. This equation has been analytically solved and 
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reduced to 
g(t) = ge - r  + f(x)(1 - e-r), 
which is evaluated with the other recursive quations by iteration. Five different compartments 
were defined according to their feedback fraction and output flux: static (resting cells), expanding 
(both cells produced by division reenter the population), steady state (one of the cells produced 
by division reenters the population), input-dependent (proliferating cells which are dependent upon 
input from another population, not feedback) and a variable amplifier (cells which varied between 
the exponentially expanding and the steady state). The model constructed had four compartments, 
the first two having variable amplifiers representing some feedback expansion and some input- 
dependent flux. The third compartment was dependent only upon the input from the second of 
the two amplifier compartments; and the fourth was the resting population resulting from the 
production of the third compartment. The model results compared favorably with experimental 
data, which was used for verification. 
A more biological approach was taken in the construction of another model of thymocyte 
production [26-28]. The three compartments of the model (Fig. 3) were the bone marrow 
compartment (where the stem cells were produced to be transported to the thymus), the blood 
vessel compartment (where nutritional considerations were simulated) and the thymus compart- 
ment (where the cellular proliferation and differentiation occurred). The equations for this model 
are shown in Table 2. The bone marrow compartment provided a mechanism for self-renewal of 
the thymocyte precursor population, as has already been described (see Theoretical Approaches to 
the Progenitor Cell Problem). Degeneration of the thymus was accomplished in the model by the 
progressive increase in generation time of the stem cells as the total number of divisions a particular 
cell had undergone reached the 50 divisions suggested in aging studies. Since the model was to be 
used for the study of leukemogenesis, a nutritional compartment was needed to provide some 
natural control upon the proliferation of cells which have lost their inherent control. The growth 
of tumor cells has been shown to be dependent upon the growth of blood vessels (angiogenesis) 
into the tumor to provide the nutrition required for the growth of the tumor cells. These 
considerations were included as a gate. At each time iteration, the ratio between the number of 
blood vessel cells and the number of lymphocytes was tested. If there were not enough blood 
vessels, the lymphocytes were not allowed to divide. This introduced a discontinuity into the model. 
Data were compared to that of the natural thymus, according to the cellular distribution into size 
categories, and the rates of development and degeneration of the thymus ranging from the fetal 
stage to the older adult were considered. By both criteria the model adequately described the 
biological condition. 
T cell differentiation is much more complicated and elusive than B cell differentiation. Even 
though there has been a large amount of experimental work on this topic during the past 10 years 
(since the construction of the models just described) the pathway(s) of T cell differentiation has 
not yet been determined. A return to the theoretical approach may be helpful in unraveling this 
mystery. The models could be extended to cover the separate subpopulations and the various 
hypotheses tested quantitatively. Even if that does not completely resolve the questions, the results 
will clarify the experimentation needed. 
LYMPHOCYTE MIGRATION 
From the bone marrow and the thymus, lymphocytes migrate to the peripheral lymphoid tissues, 
the spleen, lymph nodes, Peyer's patches in the intestine and other locations in the skin, lungs etc. 
The structure of these tissues and the pathways of migration through them have been reviewed 
[257-259]. The cells of the folloicles of the spleen and lymph nodes are generally limited to B cells. 
During an immune response, germinal centers appear within the follicles which represent the 
cellular proliferation of antigen-specific memory B cells. T cells are generally found in the areas 
surrounding the blood vessels in the spleen, called the periarteriole lymphatic sheath (PALS). In 
the lymph nodes, the T cells are found in the areas surrounding the follicles, called the paracortex. 
In the spleen, the marginal zone is located between the white pulp, which contains the highest 
concentration of lymphocytes, and the red pulp, which is responsible for red blood cell metabolism. 
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The marginal zone contains a specific subpopulation of B cells which do not recirculate. 
The study of prothymocyte migration is facilitated by the discovery of a marker, called B2A2 
[225, 260]. This marker is found on most (95%) bone marrow cells but the cells which will 
repopulate the thymus are in the B2A2- population. The donor cells remain B2A2- for approx. 
1 week in the irradiated host thymus. Because this is an irradiated animal, the time may not reflect 
the normal state, but these results do indicate that the early stage of development in the thymus 
may be B2A2-. Cortical thymocytes express more of the B2A2 marker than do the medullar 
thymocytes, but the marker persists on emigrants from the thymus. This provides a means for 
distinguishing between peripheral T cells and recent thymus migrants (Table 7). It has been 
established, however, that the migrant ceils from the thymus are of the medullary phenotype; i.e. 
there is no evidence of cortical cells leaving the thymus [261-264]. 
Hammond [265] has made a compartmental nalysis of the lymphocyte recirculation data of 
Ford [266] and concluded that: 80% of blood lymphocytes traversed straight hrough the spleen 
without being detained (spleen retention time = 5 min); 10% of the ceils traversed through only 
the red pulp (spleen retention time = 2.3 h); and the other 10% of lymphocytes also entered the 
marginal zone and the white pulp (spleen retention time = 5.5 h). Ropke and Everett [267] showed 
that the short-lived lymphocytes were formed continuously in the bone marrow and thymus to 
replenish the populations in circulation, and that the long-lived lymphocytes recirculate and are 
normal residents in the bone marrow. 
The migration of thymus cells through lymph nodes was followed by injection of labeled cells 
and examination of the draining node [268]. The traversing of the node was complete within 24 h 
and the cells went from the subcapsular sinus, where they entered via the lymph, along the outside 
of the follicles and into the subnodular spaces before leaving in the efferent lymph. Since only 
thymus cells were injected, no cells entered the follicles which were known to contain only B cells. 
Migration of labeled bone marrow cells into the peripheral tissues showed that migration 
occurred within 2-3 days, and that the cells were distributed in the cortex of the lymph nodes 
(mainly in the follicles) and in the follicular areas of the spleen [269-271]. 
Since hydroxyurea kills dividing cells, the depletion of tissues as a function of time gives an 
indication of the percentage of cells in a particular tissue which have recently divided, and the time 
at which a tissue is maximally depleted indicates how recently these cells have divided [135]. A 
maximum percentage depletion was reached first in the bone marrow (85% depleted 36 h after 
treatment) and thoracic duct cells (70% depleted after 36 h). In the spleen, 55% of the cells were 
depleted after 72 h. 
A comparison of the migration of T and B cells showed that, for the first few hours of migration, 
the two types of cells were localized together at the edge of the PALS in the spleen and in the 
paracortex of the lymph nodes [272]. After 6 h, the B cells migrated into the follicles and the T 
cells migrated into the central area of the PALS of the spleen. 
The vessel structure through which lymphocytes migrate is called the high endothelial venules 
(HEV). The dynamics of cell attachment to and migration across these vessels has been studied 
[273,274]. The recent demonstration of a specific receptor that allows a lymphocyte to traverse 
through the HEV of a lymph node but not through the HEV of Peyer's patches greatly facilitates 
the study of lymphocyte migration [275, 276]. 
In summary, the migration of lymphocytes from the primary lymphocyte differentiation tissues, 
bone marrow and thymus, to the peripheral tissues is an extremely important point of control in 
the immune response. The specificity of migration involves pecific lymphocyte surface molecules 
which interact with specific receptors on cells of the blood vessels in the peripheral tissues. The 
crucial question remaining unanswered is the fate of the lymphocytes produced in the primary 
tissues. 
Theoretical approaches to the lymphocyte migration problem 
A theoretical treatment of lymphocyte traffic was published in 1976 by Bell [277] using 
quantitative data obtained for lymphocytes before the experimental techniques were available for 
distinguishing subpopulations. The objective of this model was to estimate the frequency of 
cell-to-cell interactions in vivo. The estimate of specific T-B cell interactions in the sheep was 400/h 
and in the mouse, 1/h. 
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Fig. 4. A schematic representat ion of lymphocyte migrat ion,  where all numbers indiate the number  of  
cells x 105 that are either contained in the organ indicated or are transferred at the indicated rate. T = T 
cells; B = B cells. 
Figure 4 is a schematic model of the migration of lymphocytes in the mouse. The migration of 
cells from the bone marrow to the thymus (105) is taken from the model THYMS [27]. The values 
given for the migration from the thymus into the blood range from the number required for 
maintenance of the steady-state condition (36 x 105/day), to the total number produced by the 
thymus (720 x 105/day), assuming no cells die there, but are disposed of somehow upon leaving 
the thymus. The value for the migration from the bone marrow to the blood (10 x 105) represents 
those surviving after approximately half the cells produced in the bone marrow die there. The total 
lymphocytes produced per day, using the smaller number of T cells, is 46 x 105, a number sufficient 
to replenish the short-lived lymphocytes of the blood and lymph (83 x 105) and to replenish a 
similar number of cells in the other peripheral tissues within 4 days. This is within the range of 
the observed turnover time of short-lived lymphocytes. The differential migration rates of T and 
B cells into different issues and the relative lifetimes of each subpopulation are subjects for future 
study. With the information ow available a budget and distribution model may be constructed 
for these populations. Such a model could predict he distribution of T and B cells among tissues 
as a check on its validity. 
CONCLUSIONS 
An extensive search of several iterature databases revealed that no theoretical treatments of 
lymphocyte differentiation have been published in the last 10 years. The earlier models all concern 
the cellular kinetics of the thymus and reflect a level of understanding from 10 years ago. Using 
the more detailed analyses of lymphocyte subpopulations ow available, it is possible to construct 
more current models of lymphocyte differentiation i  the fetal liver, adult bone marrow and 
thymus. The intent of this review was to assemble and present he information required for such 
models. In so doing, it became clear that the current technology could be further exploited to 
provide the additional quantitative data needed for model construction. For example, the 
fluorescence-activated c ll sorter can be used for both cell cycle analysis and for immunological 
marker studies. These two aspects could be combined to great advantage to provide cell cycle data 
for all the identifiable subpopulations. 
One advantage of model construction is the pressure it exerts upon the experimental work to 
get the kind of basic quantitative data needed. Without the pressure of the needs identified by the 
model, experimenters may not be motivated to provide essential information. Many times, when 
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constructing models, the data used from an experimental paper is not the main point, but rather 
control data, or a minor point that was not of interest o the author. Therefore, it is suggested 
that the field of lymphocyte differentiation would benefit greatly by the resurrection of theoretical 
approaches. 
The existing knowledge in lymphocyte differentiation has been summarized to form a basis for 
future theoretical approaches in this area. The unresolved questions in developmental lymphocyte 
kinetics include: 
(1) What are the identities, characteristics and cell cycle parameters of the lymphocyte 
progenitor cells? 
The earlier stages of lymphocyte differentiation are less defined and, in most cases, 
there is little information concerning the progenitor cells. Mathematical treatments 
can be used to predict the cellular kinetic parameters of these unknown progenitor 
cells. 
(2) What are the pathways to differentiation of lymphocytes? 
The models of the thymus constructed 10 years ago were useful to determine the 
internal consistency of the data and test alternative hypotheses of thymus function. 
The currently unresolved questions of the sequences of lymphocyte differentiation 
pathways can be tested in updated models, not only of the thymus, but also similar 
models constructed from current information on the bone marrow, fetal thymus, 
fetal liver and peripheral lymphoid tissues. 
(3) What is the fate of cells produced by the bone marrow and the thymus? How many 
of them die? Where do they die? Which ones die? What is the mechanism for selection? 
The question of the control and maintenance of the repertoire of B and T cells 
is one of the most exciting at this stage of immunology. The molecular understanding 
of the immunoglobulin and T cell receptor genes makes it now possible to consider 
these questions at the level of the structures of the receptors and the antigens. The 
optimization methods such as the iterative solution to the traveling salesman 
problem, control theory from economics and network theory from electrical 
engineering can be applied to this problem. 
(4) What is the migration and distribution of lymphocyte subpopulations in peripheral 
lymphoid tissues? 
The migration and distribution of lymphocyte subpopulations i another area 
where a theoretical treatment may be useful. In this instance, a lymphocyte budget 
for each of the peripheral tissues would include input, output and steady-state 
concentrations. Such a model could be used to test the current hypotheses of 
lymphocyte migration. 
In any consideration of mathematical models, a cautionary note must be added. Models of 
biological systems have a tendency to become so complex that they surpass their usefulness. It is 
very important for those constructing models to stay in close touch with experimental immu- 
nologists in order to keep in proper focus both the experimental work and the model construction. 
This issue has been discussed in detail elsewhere [278]. 
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